Document:

Exhibit 10.3

 

EXECUTION COPY

 

CONVERSION, VOTING AND SUPPORT AGREEMENT

 

This CONVERSION, Voting
and Support Agreement (this “Agreement”) is made and entered into as of March 7, 2022, by and among
Google LLC, a Delaware limited liability company (“Parent”), each Person listed on Schedule A hereto (each,
a “Stockholder”) and, solely for the purposes of Section 3.1, Section 4.3, Section 4.4(a),
Section 4.4(c), Section 4.5, Exhibit A, ARTICLE V, and ARTICLE VI, Mandiant, Inc.,
a Delaware corporation (the “Company”).

 

WHEREAS, Parent, the Company,
and Dupin Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”), propose to enter into
an Agreement and Plan of Merger, dated as of the date hereof (as it may be amended from time to time, the “Merger Agreement”),
which provides, among other things, for the merger of Merger Sub with and into the Company (the “Merger”), with the
Company to survive the Merger as a wholly owned subsidiary of Parent, upon the terms and subject to the conditions set forth in the Merger
Agreement (capitalized terms used herein without definition, as well as the term “control” shall have the respective meanings
specified in the Merger Agreement);

 

WHEREAS, each Stockholder
beneficially owns the number of shares of 4.5% Series A Convertible Preferred Stock, par value $0.0001 per share, of the Company
(“Company Convertible Preferred Stock”) and/or the number of shares of common stock, par value $0.0001 per share,
of the Company (“Company Common Stock”) set forth opposite such Stockholder’s name on Schedule A hereto
(such shares of Company Convertible Preferred Stock and Company Common Stock, together, the “Existing Shares”); and

 

WHEREAS, as a condition to
the willingness of Parent to enter into the Merger Agreement and as an inducement and in consideration therefor, each Stockholder is
entering into this Agreement.

 

NOW, THEREFORE, in consideration
of the foregoing, the mutual covenants and agreements set forth herein, and other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, intending to be legally bound, the parties hereto agree as follows:

 

     

     

    

 

ARTICLE I

VOTING; GRANT AND APPOINTMENT OF PROXY

 

Section 1.1     Voting.
From and after the date of this Agreement until the earliest of (a) the consummation of the Merger (including the occurrence of
the Effective Time), (b) the termination of the Merger Agreement in accordance with its terms, and (c) the entry without the
prior written consent of the Stockholders into any amendment or modification of the Merger Agreement (as it exists on the date of this
Agreement), or any written waiver of the Company’s rights under the Merger Agreement (as it exists on the date of this Agreement)
made in connection with a request from Parent, in each case, which results in a decrease in, or change in the composition of, or otherwise
adversely affects the consideration payable to holders of Company Common Stock in connection with the Merger, which extends the Termination
Date (beyond the latest date to which the Merger Agreement (as it exists on the date of this Agreement) contemplates extension of the
Termination Date), or which modifies in any material respect Article II or Article VII of the Merger Agreement (as it exists
on the date of this Agreement) in a manner that is adverse to any of the Stockholders (such earliest date, the “Expiration Date”),
each Stockholder, in its, his or her capacity as a stockholder of the Company, irrevocably and unconditionally hereby agrees, subject
to Section 1.5, that at any meeting (whether annual or special and each adjourned or postponed meeting) of the Company’s
stockholders, however called, or in connection with any written consent of the Company’s stockholders, each Stockholder will (i) appear
at such meeting (in person or by proxy) or otherwise cause all of its, his or her Existing Shares and any other shares of Company Common
Stock or Company Convertible Preferred Stock over which it has acquired beneficial ownership after the date of this Agreement (including
any shares of Company Common Stock or Company Convertible Preferred Stock acquired by means of purchase, dividend or distribution, or
issued upon the exercise of any stock options or other rights to acquire Company Common Stock or Company Convertible Preferred Stock
or the conversion of any convertible securities, the vesting of equity awards or otherwise, including the Company Convertible Preferred
Stock) (collectively, the “New Shares,” and together with the Existing Shares, the “Shares”), which
it, he or she owns as of the applicable record date, to be counted as present thereat for purposes of determining a quorum and (ii) vote
or cause to be voted (including by proxy or written consent, if applicable) all such Shares (A) in favor of the adoption of the
Merger Agreement and the approval of the transactions contemplated thereby and by the other Transaction Documents, including the Merger,
(B) in favor of any proposal to adjourn or postpone such meeting of the Company’s stockholders to a later date if there are
not sufficient votes to adopt the Merger Agreement, (C) against any action or proposal in favor of an Acquisition Proposal, without
regard to the terms of such Acquisition Proposal, and (D) against any action, proposal, transaction or agreement that would reasonably
be likely to prevent, materially impede or materially delay the Company’s or Parent’s ability to consummate the transactions
contemplated by the Merger Agreement or any other Transaction Document, including the Merger. Except as explicitly set forth in this
Section 1.1, nothing in this Agreement shall limit the right of each Stockholder to vote (including by proxy or written consent,
if applicable), in its, his or her sole discretion, in favor of, against or abstain with respect to any matters that are, at any time
or from time to time, presented for consideration to the Company’s stockholders. Nothing in this Agreement shall require any of
the Stockholders to vote in any manner with respect to any amendment or modification to the Merger Agreement or the taking of any action
that would reasonably be expected to result in the amendment, modification or waiver of a provision of the Merger Agreement, in any such
case, in a manner that (a) results in a decrease in, or change in the composition of, or otherwise adversely affects the consideration
payable to holders of Company Common Stock in connection with the Merger, (b) extends the Termination Date beyond the latest date
to which the Merger Agreement (as it exists on the date of this Agreement) contemplates extension of the Termination Date, or (c) modifies
in any material respect Article II or Article VII of the Merger Agreement (as it exists on the date of this Agreement) in a
manner that is adverse to any of the Stockholders.

 

     

     

    

 

Section 1.2     [Reserved.]

 

Section 1.3     Restrictions
on Transfers.

 

(a)            Through
Receipt of the Requisite Stockholder Approval. Absent the prior written consent of Parent, each Stockholder hereby agrees that, from
the date of this Agreement until the earlier of (x) the Expiration Date and (y) the date on which the Requisite Stockholder
Approval is obtained, such Stockholder shall not, directly or indirectly, sell, transfer, assign, tender in any tender or exchange offer,
pledge, encumber, hypothecate or similarly dispose of (by merger, by testamentary disposition, by operation of law or otherwise) (each,
a “Transfer”), either voluntarily or involuntarily, or enter into any contract, option or other arrangement or understanding
providing for the Transfer of, any rights arising from any shares of Company Convertible Preferred Stock (whether New Shares or Existing
Shares) or Company Common Stock (whether New Shares or Existing Shares) or agree to do any of the foregoing, other than (i) any
conversion of Shares of Company Convertible Preferred Stock into New Shares of Company Common Stock (which, for the avoidance of doubt,
shall then be Shares subject to the terms and conditions of this Agreement) or (ii) any Transfer to any Permitted Transferee (as
defined in that certain Securities Purchase Agreement (the “SPA”), dated as of November 18, 2020, by and between
the Company and such Stockholder, as amended by that certain Amendment to Securities Purchase Agreement, effective as of December 11,
2020) of such Stockholder, but, in each case of this clause (ii), only if, prior (and as a condition) to the effectiveness of such Transfer
(unless the transferee is a Stockholder):

 

		(A)	such Stockholder shall have given reasonable
                                            advance notice of such Transfer to Parent and the Company of such proposed Transfer and the
                                            proposed form of written undertaking by the transferee to be bound by this Agreement as if
                                            such transferee were a Stockholder;

 

		(B)	such form of undertaking shall be reasonably
                                            satisfactory in all material respects to Parent and the Company; and

 

		(C)	the transferee shall have executed and delivered,
                                            for the benefit of Parent and the Company, such undertaking to be bound by this Agreement
                                            as if such transferee were such Stockholder.

 

(b)            Exceptions.
Notwithstanding anything to the contrary set forth in this Section 1.3, a Transfer shall not include any ordinary course
Transfers by members of Stockholder of any equity interests in any Stockholder, in and of themselves, so long as any such Transfer does
not have any adverse effect on the ability of the applicable Stockholder to perform its obligations under this Agreement on the terms
set forth herein.

 

     

     

    

 

(c)            Following
Receipt of the Requisite Stockholder Approval. Without limiting any restrictions on Transfer or other obligations of each Stockholder
set forth in Article I of this Agreement, each Stockholder hereby agrees that, in connection with any Transfer of shares of Company
Convertible Preferred Stock (whether New Shares or Existing Shares) (including all in-kind dividends thereon) at any time following the
date on which the Requisite Stockholder Approval is obtained and prior to the Expiration Date, prior (and as a condition) to the effectiveness
of such Transfer (unless the transferee is a Stockholder or the Transfer is a conversion of shares of Company Convertible Preferred Stock
into shares of Company Common Stock), the following shall have occurred:

 

		(i)	such Stockholder shall have given reasonable
                                            advance notice of such Transfer to Parent and the Company of such proposed Transfer and the
                                            proposed form of written undertaking by the transferee to be bound by this Agreement as if
                                            such transferee were a Stockholder;

 

		(ii)	such form of undertaking shall be reasonably
                                            satisfactory in all material respects to Parent and the Company, and

 

		(iii)	the transferee shall have executed and
                                            delivered, for the benefit of Parent and the Company, such undertaking to be bound by this
                                            Agreement as if such transferee were such Stockholder.

 

(d)            Other
Restrictions Not Superseded. Nothing in this Agreement is intended to waive compliance with, or condone non-compliance with, any
transfer restrictions arising under applicable securities Laws or the provisions of any Contracts between any Stockholder and the Company.

 

Section 1.4     Inconsistent
Agreements. Each Stockholder hereby covenants and agrees that, except for this Agreement, it, he or she (a) shall not enter
into, at any time prior to the Expiration Date, any voting agreement or voting trust with respect to the Shares that is inconsistent
with this Agreement and (b) shall not grant, at any time prior to the Expiration Date, a proxy, consent or power of attorney with
respect to the Shares that is inconsistent with this Agreement.

 

Section 1.5     No
Obligation to Exercise Rights or Options. Nothing contained in this ARTICLE I shall require any Stockholder (or shall
entitle any proxy of such Stockholder) to (a) convert, exercise or exchange any option, convertible securities or other rights,
including any Company Option, in order to obtain any underlying New Shares or (b) vote, or execute any consent with respect to,
any New Shares underlying such options, convertible securities or other rights that have not yet been issued as of the applicable record
date for that vote or consent.

 

     

     

    

 

ARTICLE II

NO SOLICITATION

 

Section 2.1     No
Solicitation.

 

(a)            Prior
to the Expiration Date, each Stockholder (in its, his or her capacity as a stockholder of the Company) shall not, shall cause each
of its, his or her controlled Affiliates and its and their respective directors and officers to not, and shall not authorize, and
shall use its reasonable best efforts to cause, its and its controlled Affiliates’ other Representatives to not, directly or
indirectly, (i) solicit, initiate, propose or induce the making, submission or announcement of, or knowingly encourage,
facilitate or assist, any offer, inquiry, indication of interest or proposal that, in any such case, constitutes, or would
reasonably be expected to lead to, an Acquisition Proposal; (ii) furnish to any Person or Group (other than Parent, Merger Sub
or any of their respective Representatives in their capacity as such) any non-public information relating to the Company or any of
its Subsidiaries or afford to any Person or Group (other than Parent, Merger Sub or any of their respective Representatives in their
capacity as such) access to the business, properties, assets, books, records or other non-public information, or to any personnel,
of the Company or any of its Subsidiaries, in any such case in connection with any Acquisition Proposal or with the intent to induce
the making, submission or announcement of, or to knowingly encourage, facilitate or assist, an Acquisition Proposal or the making of
any offer, inquiry, indication of interest or proposal that, in any such case, constitutes or would reasonably be expected to lead
to an Acquisition Proposal, (iii) participate or engage in discussions or negotiations with any Person or Group with respect to
an Acquisition Proposal or with respect to any inquiries from third Persons about making an offer, indication of interest or
proposal relating to an Acquisition Transaction (other than informing such Persons of the provisions contained in this Section 2.1(a)),
(iv) approve, endorse or recommend any offer, inquiry, indication of interest or proposal that, in any such case, constitutes,
or would reasonably be expected to lead to, an Acquisition Proposal, (v) enter into any letter of intent, memorandum of
understanding, merger agreement, acquisition agreement or other Contract (whether written or oral, binding or non-binding) relating
to an Acquisition Transaction, (vi) solicit proxies or become a “participant” in a “solicitation” (as
such terms are defined in Rule 14A under the Exchange Act) in connection with either the proposal to approve the Merger
Agreement and the Merger or any Acquisition Proposal, (vii) initiate a stockholders’ vote with respect to an Acquisition
Proposal, or (viii) become a member of a Group with respect to any voting securities of the Company with respect to an
Acquisition Proposal (other than as a result of this Agreement) or (ix) authorize or commit to do any of the foregoing; provided
that nothing herein shall prohibit any Stockholder or any of its, his or her controlled Affiliates or Representatives from
participating in any discussions or negotiations with respect to a possible stockholders’ consent or voting agreement in
connection with an Acquisition Proposal in the event that the Company becomes, and only while the Company is, permitted to take such
actions pursuant to Section 5.3(b) or Section 5.3(d) of the Merger Agreement with respect to such Acquisition
Proposal.

 

(b) For purposes of
this Agreement, the term “Affiliate” shall have the meaning assigned to it in the Merger Agreement, but shall not include
any entity whose equity securities are registered under the Exchange Act (or are publicly traded in a foreign jurisdiction), solely by
reason of the fact that one or more nominees or representatives of any of the Stockholders serves as a member of its board of directors
or similar governing body, unless the Stockholders or their Affiliates otherwise control such entity. For purposes of this Agreement,
none of the Company, any of its Subsidiaries, Parent and Merger Sub shall be deemed to be an Affiliate of any of the Stockholders.

 

     

     

    

 

Section 2.2     Capacity.
Each Stockholder is signing this Agreement solely in its, his or her capacity as a stockholder of the Company and nothing contained herein
shall in any way limit or affect any current or future director, board observer or officer of the Company, who is a Stockholder or may
be affiliated or associated with any Stockholder or any of its, his or her Affiliates, from exercising his or her fiduciary duties as
a director, board observer or officer of the Company or from otherwise taking any action or inaction in his or her capacity as a director,
board observer and/or officer of the Company, and no such exercise of fiduciary duties or action or inaction taken in such capacity as
a director, board observer or officer shall be deemed to constitute a breach of this Agreement. Nothing in this Section 2.2
is intended to limit the obligations and agreements of the Company, or the rights and remedies of Parent and Merger Sub, under the Merger
Agreement.

 

ARTICLE III

CONVERSION

 

Section 3.1     Conversion.

 

(a)            Each
Stockholder that holds any Company Convertible Preferred Stock shall take all steps necessary, including the submission, concurrently
with the execution and delivery of this Agreement, to the Company of the Optional Conversion Notice (as defined in the Certificate of
Designations) in the form of Exhibit A to this Agreement, to convert all of such Stockholder’s Company Convertible
Preferred Stock (whether New Shares or Existing Shares), including all in-kind dividends that have accrued thereon through the date of
such conversion, into Company Common Stock at the Conversion Price (as defined in the Certificate of Designations), with such conversion
to be effective as of no later than immediately before (and subject to the occurrence of) the Effective Time, so that such Stockholder
shall not hold any Company Convertible Preferred Stock (or have any accrued dividends relating thereto or any further rights to the accrual
of any dividends relating thereto) from or after the Effective Time and so that the Company Common Stock into which such Convertible
Preferred Stock converts (including all in-kind dividends that have accrued thereon through the date of such conversion) may be converted
into the right to receive the merger consideration on and subject to the terms of the Merger Agreement. The Company hereby confirms that
it will accept such Optional Conversion Notice set forth in Exhibit A promptly upon its completion, execution and delivery to the
Company, on and subject to the terms and conditions set forth therein. Notwithstanding anything herein to the contrary, if any share
of Company Convertible Preferred Stock outstanding immediately prior to the Effective Time would be entitled to be exchanged for a Fundamental
Change Repurchase Price (as defined in the Certificate of Designations) as a result of the consummation of the Merger (it being agreed
herein that the consummation of the Merger would constitute a Fundamental Change (as defined in the Certificate of Designations)) that
exceeds the amount into which the shares of Company Common Stock, into which such share of Company Convertible Preferred Stock would
convert pursuant to this Section 3.1 and Exhibit A, then the parties to this Agreement shall promptly amend this
Agreement to provide for the repurchase, and cancelation, of such share of Company Convertible Preferred Stock by the Company immediately
before the Effective Time in exchange for the payment, by wire transfer of immediately available funds, of the applicable Fundamental
Change Repurchase Price.

 

     

     

    

 

(b)            Notwithstanding
anything herein to the contrary, this Agreement permits any Stockholder to convert such Stockholder’s Company Convertible Preferred
Stock (whether New Shares or Existing Shares) (including all in-kind dividends that have accrued thereon through the date of such conversion)
into Company Common Stock in accordance with the Certificate of Designations at any time before the Effective Time.

 

(c)            Any
Shares delivered to the Stockholders upon conversion pursuant to this Section 3.1 shall be delivered on and subject to the
applicable terms and conditions set forth in the Certificate of Designations, as well as the securities purchase agreements and registration
rights agreements between the Company and such Stockholder, as such agreements have been amended and “made available” (as
such term is used in the Merger Agreement) to Parent prior to the date of this Agreement. It is understood that, notwithstanding any
applicable legends or securities law or other restrictions on transferability, all shares of Company Common Stock, into which shares
of Company Convertible Preferred Stock (including all in-kind dividends that have accrued thereon through the date of such conversion)
have been converted as provided in Exhibit A and this Section 3.1, shall be treated in the Merger as outstanding shares
of Company Common Stock and converted into the right to receive the merger consideration on and subject to the terms of the Merger Agreement.

 

ARTICLE IV

REPRESENTATIONS, WARRANTIES AND COVENANTS

 

Section 4.1     Representations
and Warranties of each Stockholder. Each Stockholder represents and warrants to Parent as follows as of the date of this Agreement:
(a) such Stockholder has full legal right and capacity to execute and deliver this Agreement, to perform Stockholder’s obligations
hereunder and to consummate the transactions contemplated hereby, (b) (i) this Agreement has been duly executed and delivered
by such Stockholder and (ii) if such Stockholder is an entity, the execution, delivery and performance of this Agreement by such
Stockholder and the consummation of the transactions contemplated hereby have been duly authorized by all necessary actions on the part
of such Stockholder and no other company or other legal entity actions or proceedings on the part of such Stockholder are necessary to
authorize this Agreement or to consummate the transactions contemplated hereby, (c) this Agreement constitutes the valid and binding
agreement of such Stockholder, enforceable against such Stockholder in accordance with its terms, except as such enforceability (i) may
be limited by applicable bankruptcy, insolvency, reorganization, moratorium and other similar Laws affecting or relating to creditors’
rights generally; and (ii) is subject to general principles of equity, (d) the execution and delivery of this Agreement by
such Stockholder does not, and the consummation of the transactions contemplated hereby and the compliance with the provisions hereof
will not, conflict with or violate any Laws or agreement binding upon such Stockholder or the Existing Shares, nor require any authorization,
consent or approval of, or filing with, any Governmental Authority, except in each case for filings with the Securities and Exchange
Commission by such Stockholder or as would not impact such Stockholder’s ability to perform or comply with its, his or her obligations
under this Agreement in any material respect, (e) as of the date of this Agreement, such Stockholder is the record owner of or beneficially
owns (as such term is used in Rule 13d-3 of the Exchange Act) the Existing Shares and does not beneficially own any other shares
of Company Common Stock or Company Convertible Preferred Stock, and (f) as of the date of this Agreement, such Stockholder beneficially
owns the Existing Shares free and clear of any proxy, voting restriction, adverse claim or other Lien (other than any restrictions created
by this Agreement, under applicable federal or state securities Laws or pursuant to any written policies of the Company with respect
to the trading of securities in connection with insider trading restrictions, (collectively, the “Existing Liens”))
and, subject to the Existing Liens, has sole voting power with respect to the Existing Shares and sole power of disposition with respect
to all of the Existing Shares, and, subject to the Existing Liens, no Person other than such Stockholder has any right to direct or approve
the voting or disposition of any of the Existing Shares; provided that each Stockholder may be deemed to share voting power and
the power of disposition over its, his or her Existing Shares with other Stockholders.

 

     

     

    

 

Section 4.2     Representations
and Warranties of Parent. Parent represents and warrants to each Stockholder as follows: (a) Parent has full legal right and
capacity to execute and deliver this Agreement, to perform Parent’s obligations hereunder and to consummate the transactions contemplated
hereby, (b) this Agreement has been duly executed and delivered by Parent and the execution, delivery and performance of this Agreement
by Parent and the consummation of the transactions contemplated hereby have been duly authorized by all necessary actions on the part
of Parent and no other company actions or proceedings on the part of Parent are necessary to authorize this Agreement or to consummate
the transactions contemplated hereby, (c) this Agreement constitutes the valid and binding agreement of Parent, enforceable against
Parent in accordance with its terms, except as such enforceability (i) may be limited by applicable bankruptcy, insolvency, reorganization,
moratorium and other similar Laws affecting or relating to creditors’ rights generally; and (ii) is subject to general principles
of equity, and (d) the execution and delivery of this Agreement by Parent does not, and the consummation of the transactions contemplated
hereby and the compliance with the provisions hereof will not, conflict with or violate any Laws or agreement binding upon Parent, nor
require any authorization, consent or approval of, or filing with, any Governmental Authority, except in each case for filings with the
Securities and Exchange Commission by Parent or as would not impact Parent’s ability to perform or comply with its obligations
under this Agreement in any material respect.

 

Section 4.3     Representations
and Warranties of the Company. The Company represents and warrants to Parent and each Stockholder as follows: (a) the Company
has full legal right and capacity to execute and deliver this Agreement, to perform the Company’s obligations hereunder and to
consummate the transactions contemplated hereby, (b) this Agreement has been duly executed and delivered by the Company and the
execution, delivery and performance of this Agreement by the Company and the consummation of the transactions contemplated hereby have
been duly authorized by all necessary actions on the part of the Company and no other company actions or proceedings on the part of the
Company are necessary to authorize this Agreement or to consummate the transactions contemplated hereby, (c) this Agreement constitutes
the valid and binding agreement of the Company, enforceable against the Company in accordance with its terms, except as such enforceability
(i) may be limited by applicable bankruptcy, insolvency, reorganization, moratorium and other similar Laws affecting or relating
to creditors’ rights generally; and (ii) is subject to general principles of equity, and (d) the execution and delivery
of this Agreement by the Company does not, and the consummation of the transactions contemplated hereby and the compliance with the provisions
hereof will not, conflict with or violate any Laws or agreement binding upon Parent, nor require any authorization, consent or approval
of, or filing with, any Governmental Authority, except in each case for filings with the Securities and Exchange Commission by the Company
or as would not impact the Company’s ability to perform or comply with its obligations under this Agreement in any material respect

 

     

     

    

 

Section 4.4     Covenants.
Each Stockholder hereby:

 

(a)            irrevocably
waives, and agrees not to exercise, any rights of appraisal or rights of dissent from the Merger that such Stockholder may have with
respect to the Shares;

 

(b)            agrees
upon receipt of written inquiry from Parent to promptly notify Parent of the number of any New Shares acquired by such Stockholder after
the date of this Agreement and prior to the Expiration Date and that any New Shares shall automatically be subject to the applicable
terms of this Agreement as though owned by such Stockholder on the date of this Agreement; and

 

(c)            agrees
to permit Parent and/or the Company to publish and disclose, including in filings with the Securities and Exchange Commission and in
the press release announcing the transactions contemplated by the Merger Agreement (the “Announcement Release”), this
Agreement and the Stockholders’ identities and ownership of the Shares and the nature of the Stockholders’ commitments, arrangements
and understandings under this Agreement, in each case, to the extent Parent and/or the Company reasonably determines that such information
is required to be disclosed by applicable Law (or in the case of the Announcement Release, to the extent the information contained therein
is consistent with other disclosures being made by Parent, the Company or the Stockholders); provided that Parent or the Company,
as applicable, shall give each Stockholder and its, his or her legal counsel a reasonable opportunity to review and comment on such publications
or disclosures prior to being made public.

 

Section 4.5     No
Other Representations. Parent and Merger Sub hereby acknowledge and agree that, except
for the representations and warranties of the Company expressly set forth in Article III of the Merger Agreement and the representations
and warranties of the Stockholders expressly set forth in Section 4.1 of this Agreement or expressly set forth elsewhere
in this Agreement (or in any other Voting Agreement executed and delivered by one or more Company Stockholders), none of the Stockholders,
the Company, their respective Affiliates, any Representative of any of the foregoing or any other Person has made, and none of Parent,
Merger Sub, any of their respective Affiliates or any Representative of any of the foregoing has relied on, any representation or warranty
regarding the Stockholders, the Company, its business, the sufficiency of the representations and warranties set forth herein or in the
Merger Agreement or any other matter in connection with the entry by Parent and Merger Sub in this Agreement, the Merger, and their respective
agreement to consummate the transactions contemplated hereby and thereby.

 

     

     

    

 

ARTICLE V

EFFECTIVENESS; TERMINATION

 

Section 5.1     No
Agreement Until Executed. Irrespective of negotiations among the parties or the exchanging of drafts of this Agreement, this Agreement
shall not constitute or be deemed to evidence a contract, agreement, arrangement or understanding between the parties unless and until
(a) the Board of Directors of the Company has approved, for purposes of any applicable anti-takeover Laws, and any applicable provision
of the Charter, Bylaws, this Agreement and the transactions contemplated by the Merger Agreement and this Agreement, (b) the Merger
Agreement is executed and delivered by all parties thereto, and (c) this Agreement is executed and delivered by all parties hereto.

 

Section 5.2     Termination.
This Agreement shall terminate automatically, without any notice or other action by any Person, and be of no further force or effect
on the Expiration Date, and none of Parent, the Company, the Stockholders and their respective Affiliates shall have any rights, obligations
or liabilities under this Agreement following such termination. Notwithstanding the preceding sentence, this ARTICLE V and
ARTICLE VI shall survive any termination of this Agreement and Section 4.4(a) shall survive the Expiration
Date if it is triggered by the Effective Time. Nothing in this ARTICLE V or Section 6.2 shall relieve or otherwise
limit any party of liability for Willful Breach of this Agreement occurring prior to such termination and for Fraud.

 

ARTICLE VI

MISCELLANEOUS

 

Section 6.1     Expenses.
Each party shall bear their respective expenses, costs and fees (including attorneys’ fees, if any) incurred in connection with
the preparation, execution and delivery of this Agreement and compliance herewith, whether or not the Merger is consummated.

 

Section 6.2     Obligations
of the Stockholders; No Survival; No Recourse. Notwithstanding anything to the contrary in this Agreement, the representations, warranties,
covenants and agreements of each Stockholder under this Agreement are several, and not joint and several, and in no event shall any Stockholder
have any obligation or liability for any of the representations, warranties, covenants and agreements under this Agreement (or under
any other agreement substantially in the form of this Agreement) of any other Stockholder or any other stockholder of the Company. Subject
to the last sentence of Section 5.2, none of the representations, warranties, covenants and agreements made by the Stockholders,
the Company, or Parent in this Agreement shall survive the consummation of the Merger. No Stockholder nor any of its Affiliates (other
than the Company) shall be liable in its capacity as a stockholder of the Company (or an Affiliate thereof) for claims, losses, damages,
expenses and other liabilities or obligations resulting from or related to breaches by the Company of the Merger Agreement.

 

     

     

    

 

Section 6.3     No
Ownership Interest. Except as specifically provided herein, (a) all rights, ownership and economic benefits of and relating
to a Stockholder’s Shares shall remain vested in and belong to such Stockholder and (b) none of Parent, the Company and their
respective Affiliates shall have any authority to exercise any power or authority to direct or control the voting or disposition of any
Shares or direct such Stockholder in the performance of its, his or her duties or responsibilities as a stockholder of the Company. Nothing
in this Agreement shall be interpreted as creating or forming a “group” with any other Person, including Parent, for purposes
of Rule 13d-5(b)(1) of the Exchange Act or any other similar provision of applicable Law.

 

Section 6.4     Notices.
All notices and other communications under this Agreement must be in writing and will be deemed to have been duly delivered and received
using one or a combination of the following methods: (a) four Business Days after being sent by registered or certified mail, return
receipt requested, postage prepaid; (b) one Business Day after being sent for next Business Day delivery, fees prepaid, via a reputable
nationwide overnight courier service; (c) immediately upon delivery by hand; or (d) on the date sent by email (except that
notice given by email will not be effective unless either (i) a duplicate copy of such email notice is promptly given by one of
the other methods described in this Section 6.4 or (ii) the receiving party delivers a written confirmation of receipt
of such notice either by email or any other method described in this Section 6.4 (excluding “out of office” or
other automated replies). In each case, the intended recipient is set forth below:

 

To Parent:

 

Google LLC

1600 Amphitheatre Parkway

Mountain View, CA 94043

Attn:                 Svilen
Karaivanov, M&A Legal

Andrew Coombs, M&A
Legal

Email:              ma-notice@google.com

 

with a copy (which shall not constitute notice)
to:

 

Freshfields Bruckhaus Deringer US LLP

601 Lexington Avenue

31st Floor

New York, New York 10022

Attn:                Ethan
A. Klingsberg

Paul M. Tiger

Email:             ethan.klingsberg@freshfields.com

paul.tiger@freshfields.com

 

     

     

    

 

To the Company:

 

Mandiant, Inc.

11951 Freedom Drive, 6th Floor

Reston, VA 20190

Attn:                 Richard
Meamber, Senior Vice President and General Counsel

Email:              richard.meamber@mandiant.com

 

with a copy (which shall not constitute notice)
to:

 

Wilson Sonsini Goodrich & Rosati

Professional Corporation

650 Page Mill Road

Palo Alto, CA 94304-1050

Attn:                 Douglas
K. Schnell

Melissa V. Hollatz

Katherine (Kathy) H. Ku

Email:             dschnell@wsgr.com

mhollatz@wsgr.com

kku@wsgr.com

 

To the Stockholders:

 

c/o
ClearSky

11231 U.S. Highway 1, #395

North Palm Beach, FL 33408

Attn:                 Jay Leek, Managing Director

Email:              jay.leek@clear-sky.com

 

with a copy (which shall not constitute notice)
to:

 

c/o ClearSky

11231 U.S. Highway 1, #395

North Palm Beach, FL 33408

Attn:                 Nick-Anthony
Buford, General Counsel

Email:              nick.buford@clear-sky.com

 

or to such other persons or addresses as may
be designated in writing by the party to receive such notice as provided above.

 

Section 6.5     Amendments;
Waivers. Any provision of this Agreement may be amended or waived if, and only if, such amendment or waiver is in writing and signed
(i) in the case of an amendment, by Parent, each Stockholder and, solely in connection with an amendment of Section 3.1,
Section 4.3, Section 4.4(a), Section 4.4(c), Section 4.5, Exhibit A, ARTICLE V,
or this ARTICLE VI, the Company, and (ii) in the case of a waiver, by the party (or parties) against whom the waiver
is to be effective. No failure or delay by any party in exercising any right, power or privilege hereunder shall operate as a waiver
thereof, nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other
right, power or privilege.

 

     

     

    

 

Section 6.6            Assignment.
Except as contemplated by Section 1.3, no party to this Agreement may assign any of its, his or her rights or obligations
under this Agreement, including by sale of stock, operation of law in connection with a merger or sale of substantially all the assets,
without the prior written consent of the other party hereto. No assignment by any party hereto shall relieve such party hereto of any
of its obligations hereunder.

 

Section 6.7            No
Partnership, Agency, or Joint Venture. This Agreement is intended to create, and creates, a contractual relationship and is not intended
to create, and does not create, any agency, partnership, joint venture or any like relationship between the parties hereto.

 

Section 6.8            Entire
Agreement. This Agreement (including Schedule A hereto), and, to the extent referenced herein, the Merger Agreement constitute
the entire agreement, and supersede all other prior and contemporaneous agreements, understandings, undertakings, arrangements, representations
and warranties, both written and oral, among the parties with respect to the subject matter hereof.

 

Section 6.9            No
Third-Party Beneficiaries. This Agreement is not intended to confer upon any person other than the parties hereto any rights or remedies
hereunder.

 

Section 6.10          Severability.
In the event that any provision of this Agreement, or the application thereof, becomes or is declared by a court of competent jurisdiction
to be illegal, void or unenforceable, the remainder of this Agreement will continue in full force and effect and the application of such
provision to other Persons or circumstances will be interpreted so as reasonably to effect the intent of the parties. The parties further
agree to modify or replace such void or unenforceable provision of this Agreement with a valid and enforceable provision that will achieve,
to the extent possible, the original economic, business and other purposes of such void or unenforceable provision.

 

Section 6.11          Remedies.
Except as otherwise provided in this Agreement, any and all remedies expressly conferred upon a party will be deemed cumulative with
and not exclusive of any other remedy conferred by this Agreement or by applicable Law on such party, and the exercise by a party of
any one remedy will not preclude the exercise of any other remedy.

 

(a)            The
parties agree that irreparable damage for which monetary damages, even if available, would not be an adequate remedy would occur in the
event that the parties do not perform the provisions of this Agreement (including any party failing to take such actions that are required
of it by this Agreement) in accordance with its specified terms or otherwise breach such provisions. The parties acknowledge and agree
that (i) the parties will be entitled, in addition to any other remedy to which they are entitled at law or in equity, to an injunction,
specific performance and other equitable relief to prevent breaches (or threatened breaches) of this Agreement and to enforce specifically
the terms of this Agreement and (ii) the right of specific enforcement is an integral part of this Agreement and without that right,
neither the Stockholders nor Parent would have entered into this Agreement.

 

     

     

    

 

(b)            The
parties agree not to raise any objections to (i) the granting of an injunction, specific performance or other equitable relief to
prevent or restrain breaches or threatened breaches of this Agreement by the Stockholders, on the one hand, or Parent, on the other hand;
and (ii) the specific performance of the terms and provisions of this Agreement to prevent breaches or threatened breaches of, or
to enforce compliance with, the covenants, obligations and agreements of the parties pursuant to this Agreement. Any party seeking an
injunction or injunctions to prevent breaches (or threatened breaches) of this Agreement and to enforce specifically the terms and provisions
of this Agreement will not be required to provide any bond or other security in connection with such injunction or enforcement, and each
party irrevocably waives any right that it may have to require the obtaining, furnishing or posting of any such bond or other security.

 

Section 6.12         Governing
Law. This Agreement is governed by and construed in accordance with the Laws of the State of Delaware.

 

Section 6.13         Consent
to Jurisdiction. Each of the parties (i) irrevocably consents to the service of the summons and complaint and any other process
(whether inside or outside the territorial jurisdiction of the Chosen Courts) in any Legal Proceeding relating to this Agreement and
the transactions contemplated by this Agreement, for and on behalf of itself, himself or herself or any of its, his or her properties
or assets, in accordance with Section 6.4 or in such other manner as may be permitted by applicable Law, but nothing in this
Section 6.13 will affect the right of any party to serve legal process in any other manner permitted by applicable Law; (ii) irrevocably
and unconditionally consents and submits itself, himself or herself and its, his or her properties and assets in any Legal Proceeding
to the exclusive general jurisdiction of the Chosen Courts in the event that any dispute or controversy arises out of this Agreement
and the transactions contemplated by this Agreement; (iii) agrees that it will not attempt to deny or defeat such personal jurisdiction
by motion or other request for leave from any Chosen Court; (iv) agrees that any Legal Proceeding arising in connection with this
Agreement and the transactions contemplated by this Agreement will be brought, tried and determined only in the Chosen Courts; (v) waives
any objection that it may now or hereafter have to the venue of any such Legal Proceeding in the Chosen Courts or that such Legal Proceeding
was brought in an inconvenient court and agrees not to plead or claim the same; and (vi) agrees that it will not bring any Legal
Proceeding relating to this Agreement and the transactions contemplated by this Agreement in any court other than the Chosen Courts.
Each of Parent and the Stockholders agrees that a final judgment in any Legal Proceeding in the Chosen Courts will be conclusive and
may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by applicable Law.

 

     

     

    

 

Section 6.14         WAIVER
OF JURY TRIAL. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY THAT MAY ARISE PURSUANT TO THIS AGREEMENT IS LIKELY TO
INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH PARTY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT THAT SUCH PARTY MAY HAVE
TO A TRIAL BY JURY IN RESPECT OF ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS
CONTEMPLATED BY THIS AGREEMENT. EACH PARTY ACKNOWLEDGES AND AGREES THAT (a) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY
HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING
WAIVER; (b) IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER; (c) IT MAKES THIS WAIVER VOLUNTARILY; AND (d) IT
HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 6.14.

 

Section 6.15         Further
Assurances. Parent, the Company and each Stockholder will each execute and deliver, or cause to be executed and delivered, all further
documents and instruments and use reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done,
all things necessary, proper or advisable under applicable Law, to consummate and make effective the transactions contemplated by this
Agreement.

 

Section 6.16         Headings.
Headings of the Articles and Sections of this Agreement are for convenience of the parties only and shall be given no substantive or
interpretive effect whatsoever.

 

Section 6.17         Interpretation.
When a reference is made in this Agreement to an Article, Section or Schedule, such reference shall be to an Article, Section or
Schedule of this Agreement unless otherwise indicated. Whenever the words “include,” “includes” or “including”
are used in this Agreement, they shall be deemed to be followed by the words “without limitation.” The words “hereof,”
 “herein” and “hereunder” and words of similar import when used in this Agreement shall refer to this Agreement
as a whole and not to any particular provision of this Agreement, unless the context otherwise requires. The word “extent”
and the phrase “to the extent” when used in this Agreement shall mean the degree to which a subject or other thing extends,
and such word or phrase shall not mean simply “if”. The definitions contained in this Agreement are applicable to the singular
as well as the plural forms of such terms and to the masculine as well as to the feminine and neuter genders of such term. References
in this Agreement to specific laws or to specific provisions of laws shall include all rules and regulations promulgated thereunder,
and any statute defined or referred to herein or in any agreement or instrument referred to herein shall mean such statute as from time
to time amended, modified or supplemented, including by succession of comparable successor statutes. Each of the parties has participated
in the drafting and negotiation of this Agreement. If an ambiguity or question of intent or interpretation arises, this Agreement must
be construed as if it is drafted by all the parties, and no presumption or burden of proof shall arise favoring or disfavoring any party
by virtue of authorship of any of the provisions of this Agreement.

 

     

     

    

 

Section 6.18     Counterparts.
This Agreement and any amendments to this Agreement may be executed in one or more counterparts, all of which will be considered one
and the same agreement and will become effective when one or more counterparts have been signed by each of the parties and delivered
to the other parties, it being understood that all parties need not sign the same counterpart. Any such counterpart, to the extent delivered
by fax or .pdf, .tif, .gif, .jpg or similar attachment to electronic mail or through an Electronic Delivery will be treated in all manner
and respects as an original executed counterpart and will be considered to have the same binding legal effect as if it were the original
signed version delivered in person. No party may raise the use of Electronic Delivery to deliver a signature, or the fact that any signature,
agreement or instrument was transmitted or communicated through the use of an Electronic Delivery, as a defense to the formation of a
contract, and each party forever waives any such defense.

 

[Signature Pages Follow]

 

     

     

    

 

IN WITNESS WHEREOF, the parties
hereto have duly executed and delivered this Agreement as of the date and year first written above.

 

	 	GOOGLE LLC,
	 	a Delaware limited liability company
	 	 	 
	 	By:	/s/ Sanjay Kapoor
	 	Name: Sanjay Kapoor
	 	Title: Vice President, Corporate Development

 

[Signature Page to Voting and Support Agreement
(ClearSky)]

 

     

     

    

 

	 	CLEARSKY SECURITY FUND I LLC,
	 	a Delaware limited liability Company
	 	 	 
	 	By:	/s/ Jay Leek
	 	Name: Jay Leek
	 	Title: Managing Director
	 	 	 
	 	CLEARSKY POWER & TECHNOLOGY FUND II LLC,
	 	a Delaware limited liability Company
	 	 	 
	 	By:	/s/ Jay Leek
	 	Name: Jay Leek
	 	Title: Managing Director

 

[Signature Page to Voting and Support Agreement
(ClearSky)]

 

     

     

    

 

	 	Solely for the purposes of Section 3.1, Section 4.3, Section 4.4(a), Section 4.4(c), Section 4.5, ARTICLE V and ARTICLE VI
	 	 	 
	 	MANDIANT, INC.
	 	a Delaware corporation
	 	 	 
	 	By:	/s/ Richard Meamber
	 	Name: Richard Meamber
	 	Title: Senior Vice President and General Counsel

 

[Signature Page to Voting and Support Agreement
(ClearSky)]

 

     

     

    

 

SCHEDULE A

 

	Stockholder	Number
    of Shares of 

Company Convertible

 Preferred Stock	Number
    of Shares of

 Company Common

 Stock
	ClearSky
    Security Fund I LLC	24,000	--1
	ClearSky
    Power & Technology Fund II LLC	6,000	--1

 

 

1
Excludes shares of Company Common Stock into which the Company Preferred Stock is convertible and of which the applicable
Stockholder may therefore be deemed to have beneficial ownership.

 

     

     

    

 

Exhibit A

 

OPTIONAL CONVERSION
NOTICE

 

Mandiant, Inc.

 

4.5% Series A
Convertible Preferred Stock

 

Subject to the terms of the Certificate of
Designations, by executing and delivering this Optional Conversion Notice, the undersigned Holder of the Convertible Preferred Stock
identified below directs the Company to convert (check one):

 

	x	all of the shares of Convertible Preferred Stock as
    of the earlier of (a) such time subsequently indicated by the Holder to the Company, and (b) immediately before (but subject
    to the occurrence of) the Effective Time (as defined in the Merger Agreement, dated as of the date of this notice, among Google LLC,
    Dupin Inc. and the Company).  

 

	 ̈	                            * shares of Convertible Preferred Stock

 

evidenced by Certificate No.  x  [N/A]                     .

 

It is understood that this notice may not
be revoked other than upon the occurrence of the Expiration Date (as defined in the Conversion, Voting and Support Agreement, dated as
of the date of this notice (the “Voting Agreement”), among Google LLC, the Company, and the Holders named therein).

 

	 	 	 	 	 
	Date:	 	 	ClearSky Security Fund
    I LLC

	 	 	 	 	(Legal Name of Holder)
	 	 	 	 	 
	 	 	 	By:	/s/ Jay Leek

	 	 	 	 	Name: Jay Leek
	 	 	 	 	Title: Managing Director
	 	 	 	 	 

 

	* 	Must be a whole number.

 

     

     

    

 

Exhibit A

 

OPTIONAL CONVERSION
NOTICE

 

Mandiant, Inc.

 

4.5% Series A
Convertible Preferred Stock

 

Subject to the terms of the Certificate of
Designations, by executing and delivering this Optional Conversion Notice, the undersigned Holder of the Convertible Preferred Stock
identified below directs the Company to convert (check one):

 

	x	all of the shares of Convertible Preferred Stock as
    of the earlier of (a) such time subsequently indicated by the Holder to the Company, and (b) immediately before (but subject
    to the occurrence of) the Effective Time (as defined in the Merger Agreement, dated as of the date of this notice, among Google LLC,
    Dupin Inc. and the Company).  

 

	 ̈	                       
         * shares of Convertible Preferred Stock

 

evidenced by Certificate
No.  x
   [N/A]                     .

 

It is understood that this notice may not
be revoked other than upon the occurrence of the Expiration Date (as defined in the Conversion, Voting and Support Agreement, dated as
of the date of this notice (the “Voting Agreement”), among Google LLC, the Company, and the Holders named therein).

 

	Date:	 	 	ClearSky Power &
    Technology Fund II LLC

	 	 	 	 	(Legal Name of Holder)
	 	 	 	 	 
	 	 	 	By:	/s/ Jay Leek

	 	 	 	 	Name: Jay Leek
	 	 	 	 	Title: Managing Director
	 	 	 	 	 

 

	* 	Must be a whole
    number.Exhibit
4.3

 

PURPLE
BIOTECH LTD. 

 

2016 EQUITY-BASED
INCENTIVE PLAN

 

1.
 PURPOSE; TYPES OF AWARDS; CONSTRUCTION.

 

1.1
 Purpose. The purpose of this 2016 Equity-Based Incentive Plan (as may be amended, the “Plan”) is to afford an incentive
to eligible employees, directors, officers, consultants, advisors, and any other person or entity whose services are considered valuable
to Purple Biotech Ltd., an Israeli company (the “Company”), or any Affiliate of the Company, which now exists or hereafter
is organized or acquired by the Company, to increase their efforts on behalf of the Company or an Affiliate and to promote the success
of the Company’s business, by providing such Grantees with opportunities to acquire a proprietary interest in the Company by the
grant of Awards pursuant to the Plan.

 

1.2.
Types of Grants. The Plan is intended to enable the Company to issue Awards under varying tax regimes, including:

 

(i)
pursuant and subject to the provisions of Section 102 of the Ordinance, and all regulations and interpretations adopted thereunder, including
the Income Tax Rules (Tax Benefits in Stock Issuance to Employees) 5763-2003 (the “Rules”) or such other rules published
by the Israeli Income Tax Authorities (the “ITA”) (such Awards, “102 Awards”). 102 Awards may either be granted
to a Trustee or without a trustee;

 

(ii)
pursuant to Section 3(9) of the Ordinance (such Awards, “3(9) Awards”);

 

(iii)
Incentive Stock Options within the meaning of Section 422 of the Code, or the corresponding provision of any subsequently enacted United
States federal tax statute, as amended from time to time, to be granted to Grantees who are deemed to be residents of the U.S. for purposes
of taxation;

 

(iv)
Nonqualified Stock Options to be granted to Grantees who are deemed to be residents of the U.S. for purposes of taxation; and

 

(v)
other stock-based Awards pursuant to Section 13 hereof.

 

In
addition to the issuance of Awards under the relevant tax regimes in the United States of America and the State of Israel, the Plan contemplates
issuances to Grantees in other jurisdictions with respect to which the Committee is empowered to make the requisite adjustments in the
Plan and set forth the relevant conditions in the Company’s agreement with the Grantee in order to comply with the requirements
of the tax regimes in any such jurisdictions.

 

The
Plan contemplates the issuance of Awards by the Company, both as a private company and as a publicly traded company.

 

1.3.
Construction. To the extent any provision herein conflict with the conditions of any relevant tax law or regulation which are relied
upon for tax relief in respect of a particular Award to a Grantee, the provisions of such law or regulation shall prevail over those
of the Plan, and the Committee is empowered hereunder to interpret and enforce the said prevailing provisions.

 

2.
DEFINITIONS.

 

2.1.
Terms Generally. The definitions of terms herein shall apply equally to the singular and plural forms of the terms defined. Whenever
the context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms. The words “include”,
“includes” and “including” shall be deemed to be followed by the phrase “without limitation.” Unless
the context requires otherwise (i) any definition of or reference to any agreement, instrument or other document herein shall be construed
as referring to such agreement, instrument or other document as from time to time amended, restated, supplemented or otherwise modified
(subject to any restrictions on such amendments, restatements, supplements or modifications set forth therein or herein), (ii) references
to any law, constitution, statute, treaty, regulation, rule or ordinance, including any section or other part thereof shall refer to
it as amended from time to time and shall include any successor thereof, (iii) reference to a person shall means an individual, partnership,
corporation, limited liability company, association, trust, unincorporated organization, or a government or agency or political subdivision
thereof, (iv) the words “herein”, “hereof” and “hereunder”, and words of similar import, shall be
construed to refer to this Plan in its entirety and not to any particular provision hereof and (v) all references herein to Sections
shall be construed to refer to Sections of this Plan.

 

     

     

    

  

2.2.
Defined Terms. The following terms shall have the meanings ascribed to them in this Section ‎ 2:

 

2.2.1.
“Affiliate” shall have the meaning assigned thereto in Rule 405 of Regulation C under the Securities Act. For the purpose
of Options granted pursuant to 102 Awards, “Affiliate” shall also mean an “employing company” within the meaning
of Section 102(a) of the Ordinance.

 

2.2.2. “ADS”
means an American Depositary Share of the Company.

 

2.2.2.A
“Applicable Law” shall mean any applicable law, rule, regulation, statute, pronouncement, policy, interpretation, judgment,
order or decree of any federal, provincial, state or local governmental, regulatory or adjudicative authority or agency, of any jurisdiction,
and the rules and regulations of any stock exchange or trading system on which the Shares are then traded or listed.

 

2.2.3.
“Award” shall mean any Option, Restricted Shares, RSU or any other Share-based award, granted to a Grantee under the Plan
and any Share issued pursuant to the exercise thereof.

 

2.2.4.
“Board” shall mean the Board of Directors of the Company.

 

2.2.5.
“Code” shall mean the United States Internal Revenue Code of 1986, as amended.

 

2.2.6.
“Committee” shall mean a committee established by the Board to administer the Plan, subject to Section ‎ 3.1; the Compensation
Committee or the Audit Committee of the Company may fulfill this role.

 

2.2.7.
“Companies Law” shall mean the Israel Companies Law-1999 and the regulations promulgated thereunder, all as amended from
time to time.

 

2.2.8.
“Controlling Shareholder” shall have the meaning set forth in Section 32(9) of the Ordinance.

 

2.2.9.
“Disability” shall mean (i) the inability of a Grantee to engage in any substantial gainful activity by reason of any medically
determinable physical or mental impairment which can be expected to result in death or which has lasted or can be expected to last for
a continuous period of not less than 12 months, as determined by a medical doctor satisfactory to the Committee or (ii) if applicable,
a “permanent and total disability” as defined in Section 22(e)(3) of the Code, or Section 409A(a)(2)(c)(i) of the Code, as
amended from time to time.

 

2.2.10.
“Employee” shall mean a person who is employed by the Company or any of its Affiliates, including, for the purpose of Section
102, an individual who is serving as an “office holder” as defined under the Companies Law, but excluding any Controlling
Shareholder.

 

2.2.11.
“Exercise Period” shall mean the period, commencing on the date of grant of an Option, during which an Option shall be exercisable,
subject to any vesting provisions thereof and the termination provisions hereof.

 

2.2.12.
“Exercise Price” shall mean the exercise price for each Share covered by an Option, which in any event shall not be less
than such minimum exercise price as determined under Applicable Law and/or by a competent authority and/or by the Tel Aviv Stock Exchange
and/or by the NASDAQ.

 

    2

     

    

 

2.2.13.
“Fair Market Value” per Share as of a particular date shall mean: (i) the closing sales price per Share on the securities
exchange (including, if applicable, the Tel Aviv Stock Exchange or the NASDAQ) on which the Shares are principally traded as quoted on
such exchange or system for the last market trading day prior to the time of determination, as reported in The Wall Street Journal or
such other source as the Committee deems reliable; without derogating from the above and solely for the purpose of determining the tax
liability pursuant to Section 102 of the Ordinance (and in particular Section 102(b)(3)), if on the date of grant the Company’s
shares are listed on any established stock exchange or a national market system or if the Company’s shares will be registered for
trading within ninety (90) days following the date of grant under the 102 Capital Gains Track, the Fair Market Value of a Share on its
date of grant shall be determined in accordance with the average value of the Company’s shares during the thirty (30) trading days
immediately preceding the date of grant (if the Company’s shares are listed on the date of grant) or during the thirty (30) trading
days immediately following the date of registration for trading (if the Company’s shares will be listed within ninety (90) days
following the date of grant), as the case may be (ii) if the Shares are then quoted in an over-the-counter market, the average of the
closing bid and asked prices for the Shares in that over-the-counter market on the last market trading day prior to the day of determination;
(iii) if the Shares are not then listed on a securities exchange or quoted in an over-the-counter market, such value as the Committee,
in its sole discretion, shall determine, with full authority to determine the method for making such determination, and which determination
shall be conclusive and binding on all parties, and shall be made after such consultations with outside legal, accounting and other experts
as the Committee may deem advisable; provided, however, that with respect to Nonqualified Stock Options, the Fair Market Value of the
Shares shall be determined in a manner that satisfies the applicable requirements of Section 409A of the Code, and with respect to Incentive
Stock Options, the Fair Market Value shall be determined in a manner that satisfies the applicable requirements of Section 422 of the
Code, subject to Code Section 422(c)(7). The Committee shall maintain a written record of its method of determining such value. If the
Shares are listed or quoted on more than one established stock exchange or over-the-counter market, the Committee shall determine the
principal such exchange or market and utilize the price of the Shares on that exchange or market (determined as per the method described
in clauses (i) or (ii) above, as applicable) for the purpose of determining Fair Market Value.

 

2.2.14.
“Grantee” shall mean an employee, director, officer, consultant, advisor, and any other person or entity who provides with
services to the Company or to any Affiliate who was granted an Award under the Plan.

 

2.2.15.
“Non-Employee” shall mean a Grantee who is not an Employee.

 

2.2.16.
“Nonqualified Stock Option” shall mean any Option granted to a Grantee who is deemed to be a resident of the U.S. for purposes
of taxation, which Option is not designated as, or does not meet the conditions for, an Incentive Stock Option.

 

2.2.17.
“Options” shall mean all options to purchase Shares granted as 102 Awards, 3(9) Awards, Incentive Stock Options and Non-Qualified
Stock Options, as well as options to purchase Shares issued under other tax regimes.

 

2.2.18.
“Ordinance” shall mean the Israeli Income Tax Ordinance (New Version) 1961, and the regulations promulgated thereunder, all
as amended from time to time.

 

2.2.19.
“Parent” shall mean any company (other than the Company), which now exists or is hereafter organized, (i) in an unbroken
chain of companies ending with the Company if, at the time of granting an Award, each of the companies (other than the Company) owns
stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other companies
in such chain, or (ii) if applicable, as defined in Section 424(e) of the Code.

 

2.2.20.
“Retirement” shall mean a Grantee’s retirement pursuant to applicable law or in accordance with the terms of any tax-qualified
retirement plan maintained by the Company or any of its affiliates in which the Grantee participates.

 

2.2.21.
“Securities Act” shall mean the U.S. Securities Act of 1933, as amended.

 

2.2.22.
“Shares” shall mean Ordinary Shares, no par value of the Company, and/or an ADS,
as the context may require, such other securities as may be substituted for such Share as set forth in this Plan, or shares
of such other class of shares of the Company as shall be designated by the Board in respect of the relevant Award.

 

2.2.23.
“Subsidiary” shall mean any company (other than the Company), which now exists or is hereafter organized or acquired by the
Company, (i) in an unbroken chain of companies beginning with the Company if, at the time of granting an Award, each of the companies
other than the last company in the unbroken chain owns stock possessing fifty percent (50%) or more of the total combined voting power
of all classes of stock in one of the other companies in such chain, or (ii) if applicable, as defined in Section 424(f) of the Code.

 

2.2.24.
“Ten Percent Shareholder” shall mean a Grantee who, at the time an Incentive Stock Option is granted, owns shares possessing
more than ten percent (10%) of the total combined voting power of all classes of shares of the Company or any Parent or Subsidiary.

 

    3

     

    

 

2.2.25.
“Trustee” shall mean the trustee appointed by the Committee or the Board, as the case may be, to hold the respective Options
and/or Shares (and, in relation with 102 Awards, approved by the Israeli tax authorities), if so appointed.

 

3.
ADMINISTRATION.

 

3.1.
To the extent permitted under Applicable Law and the Memorandum of Association, Amended and Restated Articles of Association and any
other governing document of the Company, the Plan shall be administered by the Committee. In the event that the Board does not create
a committee to administer the Plan, the Plan shall be administered by the Board in its entirety. In the event that an action necessary
for the administration of the Plan is required under law to be taken by the Board, then such action shall be so taken by the Board. In
any such event, all references herein to the Committee shall be construed as references to the Board.

 

3.2.
The Committee shall consist of two or more directors of the Company, as determined by the Board. The Board shall appoint the members
of the Committee, it may from time to time remove members from, or add members to, the Committee, and it shall fill vacancies on the
Committee however caused, provided that the composition of the Committee shall at all times be in compliance with any mandatory requirements
of Applicable Law. The Committee may select one of its members as its Chairman and shall hold its meetings at such times and places as
it shall determine. The Committee may appoint a Secretary, who shall keep records of its meetings and shall make such rules and regulations
for the conduct of its business, as it shall deem advisable and subject to requirements of Applicable Law.

 

3.3.
Subject to the terms and conditions of this Plan and any mandatory provisions of Applicable Law, and in addition to the Committee’s
powers contained elsewhere in this Plan, the Committee shall have full authority in its discretion, from time to time and at any time,
to determine any of the following, or to recommend to the Board any of the following if it is not authorized to take such action according
to Applicable Law:

 

(i)
the identity of eligible Grantees;

 

(ii)
grants of Awards and setting the terms and provisions of Option Agreements (which need not be identical) and any other agreements or
instruments under which Awards are made, including, but not limited to, the number of Shares underlying each Award;

 

(iii)
the time or times at which Awards shall be granted;

 

(iv)
the vesting schedule, the vesting milestones (if applicable), the acceleration thereof and conditions on which Awards may be exercised;

 

(v)
the Exercise Price;

 

(vi)
the interpretation of the Plan;

 

(vii)
prescription, amendment and rescission of rules and regulations relating to and for carrying out the Plan, as it may deem appropriate;

 

(viii)
the Fair Market Value of the Shares;

 

(ix)
the tax track (capital gains, ordinary income track or any other track available under the Section 102 of the Ordinance) for the purpose
of 102 Awards; and

 

(x)
any other matter which is necessary or desirable for, or incidental to, the administration of the Plan and any Award thereunder.

 

3.4.
Grants of Awards shall be made pursuant to written notice to Grantees setting forth the terms of the Award. Such notice shall designate
the type of Award as one or more of the following, subject to Applicable Law: (i) a 102 Award granted to a Trustee (either as a 102 Award
(capital gain track) with Trustee or a 102 Award (ordinary income track) with Trustee), (ii) a 102 Award without a Trustee, (iii) a 3(9)
Award, (iv) an Incentive Stock Option, (v) a Nonqualified Stock Option, or (vi) any other type of Award.

 

    4

     

    

  

3.5.
Subject to the mandatory provisions of Applicable Law, the grant of any Award, whether by the Committee or the Board, shall be deemed
to include an authorization of the issuance of Shares upon the due exercise thereof.

 

3.6.
The authority granted hereunder includes the authority to modify Awards to eligible individuals who are foreign nationals or are individuals
who are employed outside Israel to recognize differences in local law, tax policy or custom, in order to effectuate the purposes of the
Plan but without amending the Plan. The Committee shall have the authority to grant, in its discretion, to the holder of an outstanding
Award, in exchange for the surrender and cancellation of such Award, a new Award having an Exercise Price lower than that provided in
the Award so surrendered and canceled and containing such other terms and conditions as the Committee may prescribe in accordance with
the provisions of the Plan or to set a new Exercise Price for the same Award lower than that previously provided in the Award, provided
that in any event the exercise price shall not be less than such minimum exercise price as determined under Applicable Law and/or by
a competent authority and/or by the Tel Aviv Stock Exchange.

 

3.7.
All decisions, determination and interpretations of the Committee shall be final and binding on all Grantees of any Awards under this
Plan, unless otherwise determined by the Board. No member of the Committee shall be liable for any action taken or determination made
in good faith with respect to the Plan or any Award granted hereunder.

 

4.
ELIGIBILITY.

 

4.1.
Awards may be granted to Grantees of the Company or any Affiliate thereof, taking into account the qualification under each tax regime
pursuant to which such Awards are granted. A person who has been granted an Award hereunder may be granted additional Awards, if the
Committee shall so determine, subject to the limitations herein. In determining the persons to whom Awards shall be granted and the number
of Shares to be covered by each Award, the Committee shall take into account the duties of the respective persons, their present and
potential contributions to the success of the Company and such other factors as the Committee shall deem relevant in connection with
accomplishing the purpose of the Plan.

 

4.2.
Subject to Applicable Law, 102 Awards may not be granted to Controlling Shareholders and may only be granted to Employees, including
officers and directors, of the Company or any Affiliate thereof, who are Israeli residents (“Eligible 102 Grantees”). Awards
to Eligible 102 Grantees in Israel shall be 102 Awards. Eligible 102 Grantees may receive only 102 Awards, which may either be grants
to a Trustee or grants under Section 102 without a trustee; provided; however, that a 102 Award granted to an Eligible 102 Grantee who
is also a citizen or resident for U.S. tax purposes may also be deemed an Incentive Stock Option. Unless otherwise permitted by the Ordinance
and the Rules, no 102 Awards to a Trustee may be granted until the expiration of thirty (30) days after the requisite filings under the
Ordinance and the Rules have been appropriately made with the ITA.

 

4.3.
Subject to Applicable Law, Non-Employees who are Israeli residents and are not Eligible 102 Grantees may only be granted 3(9) Awards
under this Plan.

 

5.
SHARES.

 

The
number of Shares reserved for the grant of Awards under the Plan shall be 35,000,000 Ordinary Shares, no par value of the Company or
the equivalent number of ADSs representing such number of Ordinary Shares. All of the Shares reserved for issuance under the Plan may
be issued pursuant to the exercise of Incentive Stock Options. The class of Shares shall be designated by the Board with respect to each
Award and the notice of grant shall reflect such designation. Any Share underlying an Award granted hereunder which has expired, or was
cancelled or terminated or forfeited for any reason without having been exercised, shall be automatically, and without any further action
on the part of the Company or any Grantee, returned to the “pool” of reserved Shares hereunder and shall again be available
for grant for the purposes of this Plan (unless this Plan shall have been terminated) or unless the Board determines otherwise. Notwithstanding
the other provisions of this Section 5, the Board may, subject to any other approvals required under any Applicable Law, increase or
decrease the number of Shares to be reserved under the Plan. Such Shares may, in whole or in part, be authorized but unissued Shares
or Shares that shall have been or may be reacquired by the Company (to the extent permitted pursuant to the Companies Law) or by a trustee
appointed by the Board under the relevant provisions of the Ordinance, the Companies Law or any equivalent provision. Any Shares that
are not subject to outstanding Awards at the termination of the Plan shall cease to be reserved for the purpose of the Plan, but until
termination of the Plan, the Company shall at all times reserve a sufficient number of Shares to meet the requirements of the Plan.

 

    5

     

    

 

6.
TERMS AND CONDITIONS OF OPTIONS.

 

Each
Option granted pursuant to the Plan shall be evidenced by a written agreement between the Company and the Grantee or a written notice
delivered by the Company and accepted by the Grantee (an “Option Agreement”), in such form and containing such terms and
conditions as the Committee shall from time to time approve, which Option Agreement shall comply with and be subject to the following
terms and conditions, unless otherwise specifically provided in such Option Agreement or the terms referred to in Sections ‎ 9 and
‎ 10 below. For purposes of interpreting this Section‎ 6, a director’s service as a member of the Board or the services
of an officer, as the case may be, shall be deemed to be employment with the Company or its Subsidiary or Affiliate.

 

6.1.
Number of Shares. Each Option Agreement shall state the number of Shares covered by the Option.

 

6.2.
Type of Option. Each Option Agreement shall specifically state the type of Option granted thereunder and whether it constitutes an Incentive
Stock Option, Nonqualified Stock Option, 102 Option Award and the relevant track, 3(9) Option Award, and/or otherwise.

 

6.3.
Exercise Price. Each Option Agreement shall state the Exercise Price. In the case of an Incentive Stock Option, the Exercise Price shall
not be less than one hundred percent (100%) of the Fair Market Value of the Shares covered by the Option on the date of grant or such
other price as may be required pursuant to the Code. For an Incentive Stock Option granted to any Ten-Percent Shareholder, the Exercise
Price shall be no less than 110% of the Fair Market Value of the Shares covered by the Option on the date of grant. The Exercise Price
of a Nonqualified Stock Option shall not be less than 100% of the Fair Market Value of the Shares on the date of grant unless the Committee
specifically indicates that the Option will have a lower Exercise Price and the Option complies with Section 409A of the Code. In the
case of any other Option, the per share Exercise Price shall be equal to the Fair Market Value of the Shares on the date of grant, or
such other price as shall be determined by the Committee, provided, however, that in no event shall the Exercise Price of an Option be
less than the par value of the shares for which such Option is exercisable. Subject to Section‎ 3 and to the foregoing, the Committee
may reduce the Exercise Price of any outstanding Option. The Exercise Price shall also be subject to adjustment as provided in Section
14 hereof. This Section 6.3 shall not apply to an Option granted pursuant to assumption of, or substitution for, another option in a
manner that complies with Code Section 424(a), whether or not the Option is an Incentive Stock Option. In any event the exercise price
shall not be less than such minimum exercise price as determined under Applicable Law and/or by a competent authority and/or by the Tel
Aviv Stock Exchange.

 

6.4.
Manner of Exercise. An Option may be exercised, as to any or all Shares as to which the Option has become exercisable, by written notice
delivered in person or by mail to the Secretary of the Company or to such other person as determined by the Committee, specifying the
number of Shares with respect to which the Option is being exercised, accompanied by payment of the Exercise Price for such Shares in
the manner specified in the following sentence. Payment for Shares acquired pursuant to Options granted hereunder shall be made in full,
upon exercise of the Options: (i) in immediately available funds, or by certified or bank cashier’s check payable to the Company,
(ii) solely to the extent permitted by Applicable Law and authorized by the Committee, by delivery of Shares to the Company (either by
actual delivery or attestation) having a value equal to the Exercise Price, (iii) solely to the extent permitted by Applicable Law and
authorized by the Committee, by a broker-assisted cashless exercise in accordance with procedures approved by the Committee under Regulation
T as promulgated by the Federal Reserve Board, whereby payment of the Option exercise price or tax withholding obligations may be satisfied,
in whole or in part, with Shares subject to the Option by delivery of an irrevocable direction to a securities broker (on a form prescribed
by the Committee) to sell Shares and to deliver all or part of the sale proceeds to the Company in payment of the aggregate exercise
price and, if applicable, the amount necessary to satisfy the Company’s withholding obligations prior to the issuance of the Shares
subject to the Option, (iv) solely to the extent permitted by Applicable Law and authorized by the Committee, by delivery of a notice
of “net exercise” to the Company, pursuant to which the Company will reduce the number of Shares issuable upon exercise by
the largest whole number of Shares with a Fair Market Value that does not exceed the aggregate Exercise Price); provided, however, that
the Company will accept a cash or other payment from the Participant to the extent of any remaining balance of the aggregate Exercise
Price not satisfied by such reduction in the number of whole shares to be issued or (v) by any other means approved by the Committee
and specified in the Award Agreement, which may include procedures for cashless exercise. Anything herein to the contrary notwithstanding,
if the Committee determines that any form of payment available hereunder would be in violation of Section 402 of the Sarbanes-Oxley Act
of 2002, such form of payment shall not be available.

 

    6

     

    

 

6.5.
Term and Vesting of Options. Each Option Agreement shall provide the vesting schedule for the Option as determined by the Committee.
To the extent permitted under Applicable Law, the Committee shall have the authority to determine the vesting schedule and accelerate
the vesting of any outstanding Option at such time and under such circumstances as it, in its sole discretion, deems appropriate, including,
for avoidance of doubt, acceleration for change of control as such is defined in an agreement with the applicable Grantee. The Option
Agreement may contain performance goals and measurements, and the provisions with respect to any Option need not be the same as the provisions
with respect to any other Option. The Exercise Period of an Option will be 10 years from the date of grant of the Option unless otherwise
determined by the Committee, but subject to the vesting provisions described above and the early termination provisions set forth in
Sections ‎ 6.6 and ‎ 6.7 hereof; provided, however, that in the case of an Incentive Stock Option granted to a Ten Percent Shareholder,
such Exercise Period shall not exceed five (5) years from the date of grant of such Option. At the expiration of the Exercise Period,
all unexercised Options shall become null and void.

 

6.6.
Termination.

 

6.6.1.
Except as provided in this Section‎ 6.6 and in Section‎ 6.7 hereof, an Option may not be exercised unless the Grantee is then
in the employ of or maintaining a director, officer, consultant, advisor or supplier relationship with the Company or a Subsidiary or
Affiliate thereof or, in the case of an Incentive Stock Option, a company or a parent or subsidiary company of such company issuing or
assuming the Option in a transaction to which Section 424(a) of the Code applies, and unless the Grantee has remained continuously so
employed or in the director, officer, supplier, consultant, or advisor relationship since the date of grant of the Option. In the event
that the employment or director, officer or consultant, advisor or supplier relationship of a Grantee shall terminate (other than by
reason of death, Disability or Retirement), all Options of such Grantee that are vested and exercisable at the time of such termination
may, unless earlier terminated in accordance with their terms, be exercised within up to twelve (12) months after the date of such termination
(or such different period as the Committee shall prescribe); provided, however, that if the Company (or the Subsidiary or Affiliate,
when applicable) shall terminate the Grantee’s employment or service for Cause (as defined below) or if, whether or not the Grantee’s
employment is terminated by either party, circumstances arise or are discovered with respect to the Grantee that would have constituted
Cause for termination of his or her employment or service, all Options theretofore granted to such Grantee (whether vested or not) shall,
to the extent not theretofore exercised, terminate on the date of such termination (or on which such circumstances arise or are discovered,
as the case may be) unless otherwise determined by the Committee.

 

6.6.2.
In the case of a Grantee whose principal employer is a Subsidiary or Affiliate, the Grantee’s employment shall also be deemed terminated
for purposes of this Section ‎ 6.6 as of the date on which such principal employer ceases to be such Subsidiary or Affiliate. Notwithstanding
anything to the contrary, the Committee, in its absolute discretion may, on such terms and conditions as it may determine appropriate,
extend the periods for which the Options held by any individual may continue to vest and be exercisable; provided, that such Options
may lose their status as Incentive Stock Options under applicable law and be deemed Nonqualified Stock Options as a result of the modification
of the Option to extend the exercise period and/or in the event that the Option is exercised beyond the later of: (i) three (3) months
after the date of termination of the employment relationship ; or (ii) the applicable period under Section ‎ 6.7 below with respect
to a termination of the employment relationship because of the death, Disability or Retirement of Grantee.

 

6.6.3.
For purposes of this Plan, the term “Cause” shall mean any of the following: (a) fraud, embezzlement or felony or similar
act by the Grantee; (b) an act of moral turpitude by the Grantee, or any act that causes significant injury to the reputation, business,
assets, operations or business relationship of the Company (or a Subsidiary or Affiliate, when applicable); (c) any material breach by
the Grantee of an agreement between the Company or any Subsidiary or Affiliate and the Grantee (including material breach of confidentiality,
non-competition or non-solicitation covenants) or of any duty of the Grantee to the Company or any Subsidiary or Affiliate thereof; or
(d) any circumstances that constitute grounds for termination for cause under the Grantee’s employment, consulting or service agreement
with the Company or Subsidiary or Affiliate, to the extent applicable.

 

6.7.
Death, Disability or Retirement of Grantee. If a Grantee shall die while employed by, or performing service for, the Company or a Subsidiary,
or within the three (3) month period after the date of termination of such Grantee’s employment or service (or within such different
period as the Committee may have provided pursuant to Section ‎ 6.6 hereof), or if the Grantee’s employment or service shall
terminate by reason of Disability, all Options theretofore granted to such Grantee may (to the extent otherwise vested and exercisable
and unless earlier terminated in accordance with their terms), be exercised by the Grantee or by the Grantee’s estate or by a person
who acquired the right to exercise such Options by bequest or inheritance or otherwise by result of death or Disability of the Grantee,
at any time within one (1) year after the death or Disability of the Grantee (or such different period as the Committee shall prescribe).
In the event that an Option granted hereunder shall be exercised by the legal representatives of a deceased or former Grantee, written
notice of such exercise shall be accompanied by a certified copy of letters testamentary or equivalent proof of the right of such legal
representative to exercise such Option. In the event that the employment or service of a Grantee shall terminate on account of such Grantee’s
Retirement, all Options of such Grantee that are exercisable at the time of such Retirement may, unless earlier terminated in accordance
with their terms, be exercised at any time within the three (3) month period after the date of such Retirement (or such different period
as the Committee shall prescribe).

 

    7

     

    

  

6.8.
Suspension of Vesting. Unless the Board of Directors or the Committee provides otherwise, vesting of Options granted hereunder shall
be suspended during any unpaid leave of absence, other than in the case of any (a) periods of legally protected leave of absence pursuant
to Applicable Law, (b) leave of absence which was pre-approved by the Company for purposes of continuing the vesting of Options, or (c)
transfers between locations of the Company or between the Company, any Affiliate, or any respective successor thereof.

 

6.9.
Other Provisions. The Option Agreement evidencing Awards under the Plan shall contain such other terms and conditions not inconsistent
with the Plan as the Committee may determine, at or after the date of grant, including without limitation, provisions in connection with
the restrictions on transferring the Awards, which shall be binding upon the Grantees and other terms and conditions as the Committee
shall deem appropriate.

 

6.10.
Israeli Index Base for 102 Awards. Each 102 Award will be subject to the Israeli index base of the Value of Benefit, as defined in Section
102(a) of the Ordinance, as determined by the Committee in its discretion, pursuant to the Rules, from time to time. In the event that
the Company effects a public offering of its shares in any stock exchange outside of Israel, the Committee may amend retroactively the
Israeli index base, pursuant to the Rules, without the Grantee’s consent.

 

6.11.
Securities Law Restrictions. Except as otherwise provided in the applicable Option Agreement or other agreement between the Grantee and
the Company, if the exercise of an Option following the termination of the Grantee’s employment or service (other than for Cause)
would be prohibited at any time solely because the issuance of Shares would violate the registration requirements under the Securities
Act, then the Option shall terminate on the earlier of (i) the expiration of a period of six (6) months after the termination of the
Grantee’s employment or service during which the exercise of the Option would not be in violation of such registration requirements,
or (ii) the expiration of the term of the Option as set forth in the Option Agreement.

 

7.
NONQUALIFIED STOCK OPTIONS.

 

Options
granted pursuant to this Section ‎7 are intended to constitute Nonqualified Stock Options and shall be subject to the general terms
and conditions specified in Section ‎6 hereof and other provisions of the Plan, except for any provisions of the Plan applying to
Options under different tax laws or regulations. Nonqualified Stock Options may not be granted to Grantees who are providing services
only to a “parent” of the Company, as such term is defined in Rule 405 of Regulation C under the Securities Act, unless the
Shares underlying such Awards are treated as “service recipient stock” under Section 409A of the Code because the Awards
are granted pursuant to a corporate transaction (such as a spin off transaction) or unless such Awards comply with the distribution requirements
of Section 409A of the Code.

 

8.
INCENTIVE STOCK OPTIONS.

 

Options
granted pursuant to this Section ‎ 8 are intended to constitute Incentive Stock Options and shall be granted subject to the following
special terms and conditions, the general terms and conditions specified in Section ‎ 6 hereof and other provisions of the Plan,
except for any provisions of the Plan applying to Options under different tax laws or regulations:

 

8.1.
Eligibility for Awards. Incentive Stock Options may be granted only to Employees of the Company, or to Employees of a Parent or Subsidiary
corporation thereof (as such terms are defined in Sections 424(e) and 424(f) of the Code). No more than 15,000,000 Ordinary Shares may
be issued as a result of the exercise of Incentive Stock Options granted under the Plan.

 

    8

     

    

 

8.2.
Value of Shares. The aggregate Fair Market Value (determined as of the date the Incentive Stock Option is granted) of the Shares with
respect to which all Incentive Stock Options granted under this Plan and all other option plans of any Parent or Subsidiary corporation
become exercisable for the first time by each Grantee during any calendar year shall not exceed one hundred thousand United States dollars
($100,000) with respect to such Grantee. To the extent that the aggregate Fair Market Value of Shares with respect to which the Incentive
Stock Options are exercisable for the first time by any Grantee during any calendar years exceeds one hundred thousand United States
dollars ($100,000), such Options shall be treated as Nonqualified Stock Options. The foregoing shall be applied by taking Options into
account in the order in which they were granted, with the Fair Market Value of any Share to be determined at the time of the grant of
the Option. In the event that the foregoing results in the portion of an Incentive Stock Option exceeding the one hundred thousand United
States dollars ($100,000) limitation, only such excess shall be treated as a Nonqualified Stock Option.

 

8.3.
Ten Percent Shareholder. In the case of an Incentive Stock Option granted to a Ten Percent Shareholder, (i) the Exercise Price shall
not be less than one hundred and ten percent (110%) of the Fair Market Value of the Shares on the date of grant of such Incentive Stock
Option, and (ii) the Exercise Period shall not exceed five (5) years from the date of grant of such Incentive Stock Option.

 

8.4.
Incentive Stock Option Lock-Up Period. No disposition of Shares received pursuant to the exercise of Incentive Stock Options (”
ISO Shares”), shall be made by the Grantee within 2 years from the date of grant, nor within 1 year after the transfer of such
ISO Shares to the Grantee. To the extent that the Grantee violates the aforementioned limitations, the Incentive Stock Options shall
be deemed to be Nonqualified Stock Options.

 

8.5.
Approval. The status of any ISO Shares shall be subject to approval of the Plan by the Company’s shareholders, for the purposes
of qualifying the Plan with respect to the issuance of ISO Shares, and such approval to be provided 12 months before or after the date
of adoption of the Plan by the Board of Directors.

 

8.6.
Exercise Following Termination. Notwithstanding anything else in this Plan to the contrary, Incentive Stock Options that are not exercised
within three (3) months following termination of a Grantee’s employment in the Company or its Parent or Subsidiary corporations,
or within one year in case of termination of Grantee’s employment in the Company or its Parent or Subsidiary corporations due to
a Disability (within the meaning of section 22(e)(3) of the Code), shall be deemed to be Nonqualified Stock Options.

 

8.7.
Adjustments to Incentive Stock Options. Any Option Agreement providing for the grant of Incentive Stock Options shall indicate that adjustments
made pursuant to the Plan with respect to Incentive Stock Options could constitute a “modification” of such Incentive Stock
Options (as that term is defined in Section 424(h) of the Code) or could cause adverse tax consequences for the holder of such Incentive
Stock Options and that the holder should consult with his or her tax advisor regarding the consequences of such “modification”
on his or her income tax treatment with respect to the Incentive Stock Option.

 

8.8.
Notice to Company of Disqualifying Disposition. Each Grantee who receives an Incentive Stock Option must agree to notify the Company
in writing immediately after the Grantee makes a Disqualifying Disposition of any ISO Shares. A “Disqualifying Disposition”
is any disposition (including any sale) of such ISO Shares before the later of (i) two years after the date the Grantee was granted the
Incentive Stock Option, or (ii) one year after the date the Grantee acquired Shares by exercising the Incentive Stock Option. If the
Grantee dies before such ISO Shares are sold, these holding period requirements do not apply and no disposition of the ISO Shares will
be deemed a Disqualifying Disposition.

 

9.
102 AWARDS.

 

9.1.
The Company may elect to grant Awards to Grantees pursuant to this Section ‎ 9 through either (a) Section 102(b)(2) of the Ordinance
as capital gains track Awards (“102 Capital Gains Track Awards”), or (b) Section 102(b)(1) of the Ordinance as ordinary income
track Awards (“ 102 Ordinary Income Track Awards”, and together with 102 Capital Gains Track Awards, “102 Trustee Awards”).
102 Trustee Awards shall be granted subject to the following special terms and conditions contained in this Section‎ 9, the general
terms and conditions specified in Sections ‎ 6, 11 and 12 hereof and other provisions of the Plan, except for any provisions of the
Plan applying to Awards under different tax laws or regulations.

 

9.2.
The Company may grant only one type of 102 Trustee Awards at any given time to all Grantees who are to be granted 102 Trustee Awards
pursuant to this Plan, and shall file an election with the ITA regarding the type of 102 Trustee Award it elects to grant before the
date of grant of any 102 Trustee Awards (the “Election”). Such Election shall also apply to any bonus shares received by
any Grantee as a result of holding the 102 Trustee Awards. The Company may change the type of 102 Trustee Awards that it elects to grant
only after the passage of at least 12 months from the end of the year in which the first grant was made in accordance with the previous
Election, or as otherwise provided by Applicable Law. Any Election shall not prevent the Company from granting Awards pursuant to Section
102(c) of the Ordinance without a Trustee (” 102 Non-Trustee Awards”).

 

    9

     

    

 

9.3.
Each 102 Trustee Award will be deemed granted on the date stated in a written notice to be provided by the Company, provided that on
or before such date (i) the Company has provided such notice to the Trustee and (ii) the Grantee has signed all documents required pursuant
to Applicable Law and under the Plan.

 

9.4.
Each 102 Trustee Award, each Share issued pursuant to the exercise of any 102 Trustee Award, and any rights granted thereunder, including,
without limitation, bonus shares, shall be allotted and issued to and registered in the name of the Trustee and shall be held in trust
for the benefit of the Grantee for a period of not less than the requisite period prescribed by the Ordinance and the Rules or such longer
period as set by the Committee (the “Required Holding Period”). In the event that the requirements under Section 102 to qualify
an Award as a 102 Trustee Award are not met, then the Award may be treated as a 102 Non-Trustee Award, all in accordance with the provisions
of Section 102 and the Rules. After termination of the Required Holding Period, the Trustee may release such 102 Trustee Awards and any
such Shares, provided that (i) the Trustee has received an acknowledgment from the ITA that the Grantee has paid any applicable taxes
due pursuant to the Ordinance or (ii) the Trustee and/or the Company and/or its Affiliate withholds any applicable taxes due pursuant
to the Ordinance arising from the 102 Trustee Awards and/or any Shares allotted or issued upon exercise of such 102 Trustee Awards. The
Trustee shall not release any 102 Trustee Awards or Shares issued upon exercise thereof prior to the payment in full of the Grantee’s
tax liabilities arising from such 102 Trustee Awards and/or Shares or the withholding referred to in (ii) above.

 

9.5.
Each 102 Trustee Award shall be subject to the relevant terms of the Ordinance and the Rules, which shall be deemed an integral part
of the 102 Trustee Award and shall prevail over any term contained in the Plan or Award Agreement that is not consistent therewith. Any
provision of the Ordinance, the Rules and any approvals by the Income Tax Commissioner not expressly specified in this Plan or an Option
Agreement, Restricted Share Agreement, Restricted Share Unit Agreement or any other agreement entered into in connection with an Award
that, as determined by the Committee, are necessary to receive or maintain any tax benefit pursuant to Section 102 shall be binding on
the Grantee. Each Grantee granted a 102 Trustee Award shall comply with the Ordinance and the terms and conditions of the Trust Agreement
entered into between the Company and the Trustee. Each Grantee agrees to execute any and all documents that the Company and/or its Affiliates
and/or the Trustee may reasonably determine to be necessary in order to comply with the Ordinance and the Rules.

 

9.6.
During the Required Holding Period, each Grantee shall not release from trust or sell, assign, transfer or give as collateral, the Shares
issuable upon the exercise of a 102 Trustee Awards and/or any securities issued or distributed with respect thereto, until the expiration
of the Required Holding Period. Notwithstanding the above, if any such sale or release occurs during the Required Holding Period it will
result in adverse tax consequences to the Grantee under Section 102 of the Ordinance and the Rules, which shall apply to and shall be
borne solely by such Grantee. Subject to the foregoing, the Trustee may, pursuant to a written request from a Grantee, release and transfer
such Shares to a designated third party, provided that both of the following conditions have been fulfilled prior to such release or
transfer: (i) payment has been made to the ITA of all taxes required to be paid upon the release and transfer of the Shares, and confirmation
of such payment has been received by the Trustee; and (ii) the Trustee has received written confirmation from the Company that all requirements
for such release and transfer have been fulfilled according to the terms of the Company’s corporate documents, the Plan, the relevant
Option Agreement and any Applicable Law.

  

9.7.
If a 102 Trustee Award is exercised during the Required Holding Period, the Shares issued upon such exercise shall be issued in the name
of the Trustee for the benefit of the Grantee. If such 102 Trustee Award is exercised after the expiration of the Required Holding Period,
the Shares issued upon such exercise shall, at the election of the Grantee, either (i) be issued in the name of the Trustee, or (ii)
be issued to the Company’s Nominee Company for the benefit of Grantee, provided that the Grantee first complies with all applicable
provisions of the Plan and all taxes with respect thereto shall have been fully paid to the ITA.

 

9.8.
The foregoing provisions of this Section ‎ 9 relating to 102 Trustee Awards shall not apply with respect to 102 Non-Trustee Awards,
which shall, however, be subject to the relevant provisions of Section 102 and the Rules.

 

9.9.
Upon receipt of a 102 Trustee Award, a Grantee will sign an undertaking to release the Trustee from any liability with respect to any
action or decision duly taken and executed in good faith by the Trustee in relation to the Plan, or any 102 Trustee Award or Share granted
to such Grantee thereunder.

 

    10

     

    

 

10.
3(9) AWARDS.

 

10.1.
Awards granted pursuant to this Section ‎ 10 are intended to constitute 3(9) Awards and shall be granted subject to the general terms
and conditions specified in Section 6 hereof and other provisions of the Plan, except for any provisions of the Plan applying to Awards
under different tax laws or regulations.

 

10.2.
To the extent required by the Ordinance or the ITA or otherwise deemed by the Committee prudent or advisable, 3(9) Awards granted pursuant
to the Plan shall be issued to a Trustee nominated by the Committee in accordance with the provisions of the Ordinance. In such event,
the Trustee shall hold such Awards in trust, until exercised by the Grantee, pursuant to the Company’s instructions from time to
time as set forth in a trust agreement, which will be entered into between the Company and the Trustee. If determined by the Board or
the Committee, and subject to such trust agreement, the Trustee shall be responsible for withholding any taxes for which a Grantee may
become liable upon the exercise of Awards.

 

11.
RESTRICTED SHARES

 

The
Committee may award Restricted Shares to any eligible Grantee, including under Section 102 of the Ordinance. Each Award of Restricted
Shares under the Plan shall be evidenced by a written agreement between the Company and the Grantee (a “Restricted Share Agreement”),
in such form as the Committee shall from time to time approve. Each Restricted Share Agreement shall comply with and be subject to the
following terms and conditions, unless otherwise specifically provided in such Agreement:

 

11.1.
Number of Shares. Each Restricted Share Agreement shall state the number of Shares covered by an Award.

 

11.2.
Purchase Price. Each Restricted Share Agreement may state a purchase price amount to be paid by the Grantee, if any, in consideration
for the issuance of Restricted Shares and the terms of payment thereof, which may include payment by issuance of promissory notes or
other evidence of indebtedness on such terms and conditions as determined by the Committee.

 

11.3.
Vesting. Each Restricted Share Agreement shall provide the vesting schedule for Restricted Shares as determined by the Committee, provided
that (to the extent permitted under Applicable Law) the Committee shall have the authority to determine the vesting schedule and accelerate
the vesting of any outstanding Restricted Share at such time and under such circumstances as it, in its sole discretion, deems appropriate,
including, for avoidance of doubt, acceleration for change of control as such is defined in an agreement with the applicable Grantee.

 

11.4.
Restrictions. Restricted Shares may not be sold, assigned, transferred, pledged, hypothecated or otherwise disposed of, except by will
or the laws of descent and distribution, for such period as the Committee shall determine from the date on which an Award is granted
(a “Restricted Period”). The Committee may also impose such additional or alternative restrictions and conditions on Restricted
Shares as it deems appropriate, including the satisfaction of performance criteria. Such performance criteria may include, but are not
limited to, sales, earnings before interest and taxes, return on investment, earnings per share, any combination of the foregoing or
rate of growth of any of the foregoing, as determined by the Committee. Certificates for shares issued pursuant to Restricted Share Awards
shall bear an appropriate legend referring to such restrictions, and any attempt to dispose of any such shares in contravention of such
restrictions shall be null and void and without effect. Such certificates may, if so determined by the Committee, be held in escrow by
an escrow agent appointed by the Committee, or, if a Restricted Share Award is made pursuant to Section 102, by the Trustee. In determining
the Restricted Period of an Award, the Committee may provide that the foregoing restrictions shall lapse with respect to specified percentages
of the awarded Restricted Shares on successive anniversaries of the date of such Award.

 

11.5.
Adjustment of Performance Goals. The Committee may adjust performance goals to take into account changes in law and accounting and tax
rules and to make such adjustments as the Committee deems necessary or appropriate to reflect the inclusion or the exclusion of the impact
of extraordinary or unusual items, events or circumstances. The Committee also may adjust the performance goals by reducing the amount
to be received by any Grantee pursuant to an Award if and to the extent that the Committee deems it appropriate.

 

11.6.
Forfeiture. Subject to such exceptions as may be determined by the Committee, if a Grantee’s continuous employment with the Company
or any Subsidiary or Affiliate shall terminate for any reason prior to the expiration of the vesting date or Restricted Period of an
Award or prior to the payment in full of the purchase price for any Restricted Shares with respect to which the vesting date or the Restricted
Period has expired, any Shares remaining subject to vesting or restrictions or with respect to which the purchase price has not been
paid in full, shall thereupon be forfeited and shall be deemed transferred to, and reacquired by, or cancelled by, as the case may be,
the Company or a Subsidiary at no cost to the Company or Subsidiary, subject to all Applicable Laws. Upon forfeiture of Restricted Shares,
the Grantee shall have no further rights with respect to such Restricted Shares.

 

    11

     

    

 

11.7.
Ownership. During a Restricted Period, a Grantee shall possess all incidents of ownership of Restricted Shares, subject to Sections ‎
6.9 and ‎ 11.4, including the right to vote and receive dividends with respect to such Shares. All distributions, if any, received
by a Grantee with respect to Restricted Shares as a result of any stock split, stock dividend, combination of shares, or other similar
transaction shall be subject to the restrictions applicable to the original Award.

 

12.
RESTRICTED SHARE UNITS.

 

12.1.
A Restricted Share Unit (“RSU”) is an Award covering a number of Shares that is settled by issuance of those Shares. An RSU
may be awarded to any eligible Grantee, including under Section 102 of the Ordinance. Each grant of RSUs under the Plan shall be evidenced
by a written agreement between the Company and the Grantee (the “Restricted Share Unit Agreement”), in such form as the Committee
shall from time to time approve. RSUs shall be subject to all applicable terms of the Plan and may be subject to any other terms that
are not inconsistent with the Plan. The provisions of various Restricted Share Unit Agreements entered into under the Plan need not be
identical. RSUs may be granted in consideration of a reduction in the recipient’s other compensation.

 

12.2.
Other than the par value of the Shares, no payment of cash shall be required as consideration for RSUs. RSUs may or may not be subject
to vesting. Vesting shall occur, in full or in installments, upon satisfaction of the conditions specified in the relevant Restricted
Share Unit Agreement.

 

12.3.
Without limitation of Section‎ 6.9, no voting or dividend rights as a shareholder shall exist prior to the actual issuance of Shares
in the name of a Grantee. Notwithstanding anything else in this Plan (as may be amended from time to time) to the contrary, unless otherwise
specified by the Committee, each RSU shall be for a term of ten (10) years. Each Restricted Share Unit Agreement shall specify its term
and any conditions on the time or times for settlement, and provide for expiration prior to the end of its term in the event of termination
of employment or service providing to the Company, and may provide for earlier settlement in the event of a Grantee’s death, Disability
or other events.

 

12.4.
Settlement of vested RSUs shall be made in the form of Shares. Distribution to a Grantee of an amount (or amounts) from settlement of
vested RSUs can be deferred to a date after settlement as determined by the Committee. The amount of a deferred distribution may be increased
by an interest factor or by dividend equivalents. Until a grant of RSUs is settled, the number of such RSUs shall be subject to adjustment
pursuant hereto.

 

12.5.
Notwithstanding anything to the contrary set forth herein, any RSUs granted under the Plan that are not exempt from the requirements
of Section 409A of the Code shall contain such restrictions or other provisions so that such RSUs will comply with the requirements of
Section 409A of the Code. Such restrictions, if any, shall be determined by the Board and contained in the Restricted Share Unit Agreement
evidencing such RSU Award. For example, such restrictions may include, without limitation, a requirement that any Shares that are to
be issued in a year following the year in which the RSU Award vests must be issued in accordance with a fixed, pre-determined schedule.

 

13.
OTHER SHARE OR SHARE-BASED AWARDS.

 

The
Committee may grant other Awards under the Plan pursuant to which Shares (which may, but need not, be Restricted Shares pursuant to Section
11 hereof), cash or a combination thereof, are or may in the future be acquired or received, or Awards denominated in stock units, including
units valued on the basis of measures other than market value. The Committee may also grant stock appreciation rights without the grant
of an accompanying Option, which rights shall permit the Grantees to receive, at the time of any exercise of such rights, cash equal
to the amount by which the Fair Market Value of all Shares in respect of which the right was granted exceeds the exercise price thereof.
The Committee may grant to Grantees (including Employees), and it is hereby deemed to be an Award under the terms of the Plan, the opportunity
to purchase Shares of the Company in connection with any public offerings of the Company’s securities, including a rights offering
to Shareholders of the Company. Such other Share based Awards may be granted alone, in addition to, or in tandem with, any Award of any
type granted under the Plan and must be consistent with the purposes of the Plan.

 

    12

     

    

  

14.
EFFECT OF CERTAIN CHANGES.

 

14.1.
General. In the event of a subdivision of the outstanding share capital of the Company, a recapitalization, a reorganization (which may
include a combination or exchange of shares), a consolidation, a stock split, a reverse stock split, a spin-off or other corporate divestiture
or division, a reclassification or other similar occurrence, the Committee shall make such adjustments as determined by it to be appropriate
in order to adjust (i) the number of Shares available for grants of Awards, (ii) the number of Shares covered by outstanding Awards,
and (iii) the exercise price per Share covered by any Award; provided, however, that any fractional Shares resulting from such adjustment
shall be rounded down to the nearest whole Share, and the Company shall have no obligation to make any cash or other payment with respect
to such fractional Shares, and provided that in any event the exercise price shall not be less than NIS 0.30 (or equivalent in other
currency) or such other minimum exercise price as determined under applicable law and/or by a competent authority and/or by the Tel Aviv
Stock Exchange.

 

14.2.
Merger and Sale of Company. In the event of (i) a sale of all or substantially all of the assets of the Company; or (ii) a sale (including
an exchange) of all or substantially all of the shares of the Company, or an acquisition by a shareholder of the Company or by an Affiliate
of such shareholder, of all of the shares of the Company held by other shareholders or by other shareholders who are not Affiliated with
such acquiring party; (iii) a merger, consolidation, amalgamation or like transaction of the Company with or into another corporation;
(iv) a scheme or arrangement for the purpose of effecting such sale, merger or amalgamation; or (v) such other transaction or set of
circumstances that is determined by the Committee, in its discretion, to be a transaction having a similar effect (all such transactions
being herein referred to as a “Merger/Sale”), then, without the Grantee’s consent and action and without any prior
notice requirement:

 

14.2.1.
Unless otherwise determined by the Committee in its sole and absolute discretion, any Award then outstanding shall be assumed or an equivalent
Award shall be substituted by such successor corporation of the Merger/Sale or any Parent or Affiliate thereof as determined by the Board
in its discretion (the “Successor Corporation”), under substantially the same terms as the Award.

 

For
the purposes of this Section ‎ 14.2.1, the Award shall be considered assumed if, following a Merger/Sale, the Award confers on the
holder thereof the right to purchase or receive, for each Share underlying an Award immediately prior to the Merger/Sale, either (i)
the consideration (whether stock, cash, or other securities or property) distributed to or received by holders of Shares in the Merger/Sale
for each Share held on the effective date of the Merger/Sale (and if holders were offered a choice of consideration, the type of consideration
chosen by the holders of a majority of the outstanding Shares), which may be subject to vesting and other terms as determined by the
Committee in its discretion, or (ii) regardless of the consideration received by the holders of Shares in the Merger/Sale, solely shares
(or their equivalent) of the Successor Corporation at a value to be determined by the Committee in its discretion, which may be subject
to vesting and other terms as determined by the Committee in its discretion. The foregoing shall not limit the Committee’s authority
to determine, in its sole discretion, that in lieu of such assumption or substitution of awards of the Successor Corporation for Awards,
any other type of asset or property will be substituted for an Award, including under Section ‎ 14.2.2 hereunder.

 

14.2.2.
In the event that Awards are not assumed or substituted for by equivalent awards, the Committee may (but shall not be obligated to),
in lieu of such assumption of, or substitution for, an Award, and in its sole discretion, (i) provide for a Grantee to have the right
to exercise an Award, or otherwise accelerate vesting of an Award, as to all or part of the Shares covered thereby, including Shares
covered by the Award which would not otherwise be exercisable or vested, under such terms and conditions as the Committee shall determine,
including the cancellation of all unexercised Awards upon closing of the Merger/Sale; and/or (ii) provide for the cancellation of each
outstanding Award at the closing of such Merger/Sale, and payment to the Grantee of an amount in cash as determined by the Committee
to be fair under the circumstances (with full authority to determine the method for making such determination, which may be the Black-Scholes
model or any other method, and which determination shall be conclusive and binding on all parties, and which may be zero if the value
of the Shares underlying an Option is determined to be less than the Exercise Price therefor), and subject to such terms and conditions
as may be determined by the Committee. Payments under this provision may be delayed to the same extent that payment of consideration
to the holders of the Company’s Shares in connection with the Merger/Sale is delayed as a result of escrows, earn outs, holdbacks
or any other contingencies.

 

    13

     

    

 

14.2.3.
Notwithstanding the foregoing, in the event of a Merger/Sale, the Committee may determine, in its sole discretion, that upon completion
of such Merger/Sale, the terms of any Award shall be otherwise amended, modified or terminated, as the Committee shall deem in good faith
to be appropriate, and if an Option Award, that the Option Award shall confer the right to purchase or receive any other security or
asset, or any combination thereof, or that its terms be otherwise amended, modified or terminated, as the Committee shall deem in good
faith to be appropriate. Neither the authorities and powers of the Committee under this Section ‎ 14.2, nor the exercise or implementation
thereof, shall (i) be restricted or limited in any way by any adverse consequences (tax or otherwise) that may result to any holder of
an Award, and (ii) as, inter alia , being a feature of the Award upon its grant, be deemed to constitute a change or an amendment of
the rights of such holder under this Plan, nor shall any such adverse consequences (as well as any adverse tax consequences that may
result from any tax ruling or other approval or determination of any relevant tax authority) be deemed to constitute a change or an amendment
of the rights of such holder under this Plan.

 

14.2.4.
The Committee need not take the same action with respect to all Awards or with respect to all Grantees. The Committee may take different
actions with respect to the vested and unvested portions of an Award.

 

14.3
Effect of distributions and rights offerings.

 

14.3.1
In case of bonus share distribution in which the record date is prior to the exercise date of vested Options, then the quantity of shares
to which the Grantee is entitled upon exercise of such Options will be increased by the number of shares to which the Grantee would have
been entitled to receive as bonus shares, had such Grantee exercised such vested options no later than the trading day preceding the
Ex-benefit date. The exercise price of the options will remain unchanged. The provisions applicable to Shares issued pursuant to the
exercise of Options (including without limitation the provisions relating to the Required Holding Period pursuant to section 9.4 above)
shall apply to all Shares issuable upon exercise of such Options.

 

14.3.2
In the event that the Company shall offer to its shareholders any securities by way of a rights issue, the exercise price of the Options
and the quantity of Shares issuable upon exercise of the Options will not be adjusted, however the Company shall offer, or cause to be
offered, rights to Grantees mutatis mutandis, in such quantity as the Grantees would have been entitled in the event that they had exercised
their vested Options one day prior to the record date for the rights issuance. The provisions herein applicable to Shares issued pursuant
to the exercise of Options (including without limitation the provisions relating to the Required Holding Period pursuant to section 9.4
above) shall apply to all securities issuable in such manner to Grantees pursuant to the rights offering (if any) - with the exception
of such quantity of the securities with an Ex-rights value equal to the amount invested by the Grantee in exercising the rights, which
securities shall be transferred (beneficially) to the Company’s Nominee Company for the benefit of Grantee following issuance thereof.

 

14.3.3.
Cash dividend distribution. No adjustments in the purchase price or quantity of options shall be implemented in the event of distribution
of a cash dividend by the Company to its shareholders.

 

14.4.
Reservation of Rights. Except as expressly provided in this Section ‎ 14, the Grantee of an Award hereunder shall have no rights
by reason of any subdivision or consolidation of shares of any class or the payment of any stock dividend (bonus shares), any other increase
or decrease in the number of shares of any class or by reason of any dissolution, liquidation, Merger/Sale, or consolidation, divestiture
or spin-off of assets or shares of another company. Any issue by the Company of shares of any class, or securities convertible into shares
of stock of any class, shall not affect, and no adjustment by reason thereof shall be made with respect to, the number, type or price
of shares subject to an Award. The grant of an Award pursuant to the Plan shall not affect in any way the right or power of the Company
to make adjustments, reclassifications, reorganizations or changes to its capital or business structures or to merge, consolidate, dissolve,
liquidate, sell or transfer all or part of its business or assets or engage in any similar transactions.

 

14.5.
In accordance with directives of the Tel Aviv Stock Exchange, due to transition to clearance on day T+1 for shares and convertible securities,
and to the extent the Tel Aviv Stock Exchange bylaws shall not determine otherwise, no Options shall be exercised on the effective date
for bonus share distribution, rights offering, dividend distribution, share capital split, reverse-split or reduction (hereinafter: a
“Corporate Event”). Furthermore, in the event that the Ex-day for a Corporate Event shall occur prior to the effective date
for a Corporate Event, no Options may be exercised on said Ex-day.

 

15.
NON-TRANSFERABILITY OF AWARDS; SURVIVING BENEFICIARY.

 

    14

     

    

 

15.1.
All Awards granted under the Plan shall not be transferable otherwise than by will or by the laws of descent and distribution, unless
otherwise determined by the Board or under this Plan, provided that with respect to Shares issued upon exercise of Options, the restrictions
on transfer shall be the restrictions referred to in Section ‎ 16 (Conditions Upon Issuance of Shares) hereof. Awards may be exercised
or otherwise realized, during the lifetime of a Grantee, only by the Grantee or by his or her guardian or legal representative, to the
extent provided herein. Any transfer of an Award not permitted hereunder (including transfers pursuant to any decree of divorce, dissolution
or separate maintenance, any property settlement, separation agreement or any other agreement with a spouse) and any grant of any interest
in any Award to, or creation in any way of any interest in any Award by, any party other than a Grantee shall be null and void and shall
not confer upon any party or person, other than the Grantee, any rights. A Grantee may file with the Committee a written designation
of a beneficiary on such form as may be prescribed by the Committee and may, from time to time, amend or revoke such designation. If
no designated beneficiary survives the Grantee, the executor or administrator of the Grantee’s estate shall be deemed to be the
Grantee’s beneficiary. Notwithstanding the foregoing, upon the request of a Grantee and subject to Applicable Law, the Committee,
at its sole discretion, may permit the Grantee to transfer an Award to a family trust.

 

15.2.
As long as Shares are held by a Trustee in favor of a Grantee, all rights possessed by the Grantee over the Shares are personal, and
may not be transferred, assigned, pledged or mortgaged, other than by will or laws of descent and distribution.

 

16.
CONDITIONS UPON ISSUANCE OF SHARES

 

16.1.
Legal Compliance. Shares shall not be issued pursuant to the exercise or settlement of an Award, unless the exercise or settlement of
such Award and the issuance and delivery of such Shares shall comply with Applicable Laws as determined by counsel to the Company. The
inability of the Company to obtain authority from any regulatory body having jurisdiction, which authority is deemed by the Company’s
counsel to be necessary for the lawful issuance and sale of any Shares hereunder, and the inability to issue Shares hereunder due to
non-compliance with any Company policies with respect to the sale of Shares, shall relieve the Company of any liability in respect of
the failure to issue or sell such Shares as to which such requisite authority or compliance shall not have been obtained or achieved.
Shares issued pursuant to an Award shall be subject to the Amended and Restated Articles of Association of the Company and any other
governing documents of the Company, including all policies, manuals and internal regulations adopted by the Company from time to time,
as may be amended from time to time, including, without limitation, any provisions included therein concerning restrictions or limitations
on transferability of Shares or grant of any rights with respect thereto and any provisions concerning restrictions on the use of inside
information and other provisions deemed by the Company to be appropriate in order to ensure compliance with Applicable Law, statutes
and regulations.

 

16.2.
Investment Representations. As a condition to the exercise of an Award, the Company may require the person exercising such Award to represent
and warrant at the time of any such exercise that the Shares are being purchased only for investment and without any present intention
to sell or distribute such Shares, and to make other representations as may be required under applicable securities laws, if, in the
opinion of counsel for the Company, such representations are required, all in form and content specified by the Company.

 

17.
MARKET STAND-OFF

 

17.1.
In connection with any underwritten public offering by the Company of its equity securities pursuant to an effective registration statement
filed under the Securities Act or equivalent law in another jurisdiction, a Grantee shall not directly or indirectly, without the prior
written consent of the Company or its underwriters, (i) lend, offer, pledge, sell, contract to sell, sell any option or contract to purchase,
purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly
or indirectly, any Shares acquired under this Plan or any securities of the Company (whether or not acquired under this Plan), or (ii)
enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership
of the Shares acquired under this Plan, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery
of Shares acquired under this Plan or such other securities, in cash or otherwise. Such restriction (the “Market Stand-Off”)
shall be in effect for such period of time following the effective date of the registration statement relating to such offering as may
be requested by the Company or such underwriters, provided, however, that in any event, such period shall not exceed 90 days following
the effective date of such registration statement.

 

17.2.
In the event of a subdivision of the outstanding share capital of the Company, the declaration and payment of a stock dividend (distribution
of bonus shares), the declaration and payment of an extraordinary dividend payable in a form other than stock, a recapitalization, reorganization
(which may include a combination or exchange of shares or a similar transaction affecting the Company’s outstanding securities
without receipt of consideration), a consolidation, stock split, spin-off or other corporate divestiture or division, a reclassification
or other similar occurrence, an adjustment in conversion ratio, any new, substituted or additional securities which are by reason of
such transaction distributed with respect to any Shares subject to the Market Stand-Off, or into which such Shares thereby become convertible,
shall immediately be subject to the Market Stand-Off.

 

    15

     

    

 

17.3.
In order to enforce the Market Stand-Off, the Company may impose stop-transfer instructions with respect to the Shares acquired under
this Plan until the end of the applicable stand-off period.

 

17.4.
The underwriters in connection with a registration statement so filed are intended to be third party beneficiaries of this Section 17
and shall have the right, power and authority to enforce the provisions hereof as though they were a party hereto.

 

18.
AGREEMENT BY GRANTEE REGARDING TAXES.

 

18.1.
If the Committee shall so require, as a condition of exercise of an Award, the release of Shares by the Trustee or the expiration of
the Restricted Period, a Grantee shall agree that, no later than the date of such occurrence, he or she will pay to the Company or make
arrangements satisfactory to the Committee and the Trustee (if applicable) regarding payment of any applicable taxes of any kind required
by Applicable Law to be withheld or paid.

 

18.2.
Each Option Agreement, Restricted Share Agreement, and Restricted Share Unit Agreement and each other agreement in connection with an
Award under the Plan shall contain the following agreement and acknowledgment of the Grantee:

 

ALL
TAX CONSEQUENCES UNDER ANY APPLICABLE LAW WHICH MAY ARISE FROM THE GRANT OF ANY AWARDS OR THE EXERCISE THEREOF, THE SALE OR DISPOSITION
OF ANY SHARES GRANTED HEREUNDER OR ISSUED UPON EXERCISE OF ANY AWARD OR FROM ANY OTHER ACTION OF A GRANTEE IN CONNECTION WITH THE FOREGOING
SHALL BE BORNE AND PAID SOLELY BY SUCH GRANTEE, AND THE GRANTEE SHALL INDEMNIFY THE COMPANY, ITS SUBSIDIARIES AND AFFILIATES AND THE
TRUSTEE, AND SHALL HOLD THEM HARMLESS AGAINST AND FROM ANY LIABILITY FOR ANY SUCH TAX OR PENALTY, INTEREST OR INDEXATION THEREON. EACH
GRANTEE AGREES TO, AND UNDERTAKES TO COMPLY WITH, ANY RULING, SETTLEMENT, CLOSING AGREEMENT OR OTHER SIMILAR AGREEMENT OR ARRANGEMENT
WITH ANY TAX AUTHORITY IN CONNECTION WITH THE FOREGOING WHICH IS APPROVED BY THE COMPANY. EACH GRANTEE IS ADVISED TO CONSULT WITH A TAX
ADVISOR WITH RESPECT TO THE TAX CONSEQUENCES OF RECEIVING OR EXERCISING AWARDS HEREUNDER. THE COMPANY DOES NOT ASSUME ANY RESPONSIBILITY
TO ADVISE A GRANTEE ON SUCH MATTERS, WHICH SHALL REMAIN SOLELY THE RESPONSIBILITY OF SUCH GRANTEE.

 

18.3.
The Company or any Subsidiary or Affiliate may take such action as it may deem necessary or appropriate, in its discretion, for the purpose
of or in connection with withholding of any taxes which the Company or any Subsidiary or Affiliate is required by any Applicable Law
to withhold in connection with any Awards (collectively, “Withholding Obligations”). Such actions may include, without limitation,
(i) requiring a Grantee to remit to the Company in cash an amount sufficient to satisfy such Withholding Obligations; (ii) subject to
Applicable Law, allowing a Grantee to surrender Shares to the Company, in an amount that at such time, reflects a value that the Committee
determines to be sufficient to satisfy such Withholding Obligations; (iii) withholding Shares otherwise issuable upon the exercise of
an Award at a value which is determined by the Committee to be sufficient to satisfy such Withholding Obligations; or (iv) any combination
of the foregoing. The Company shall not be obligated to allow the exercise of any Award by or on behalf of a Grantee until all tax consequences
arising from the exercise of such Award are resolved in a manner acceptable to the Company.

 

18.4.
Each Grantee shall notify the Company in writing promptly and in any event within ten (10) days after the date on which such Grantee
first obtains knowledge of any tax bureau inquiry, audit, assertion, determination, investigation, or question relating in any manner
to the Awards granted or received hereunder or Shares issued hereunder and shall continuously inform the Company of any developments,
proceedings, discussions and negotiations relating to such matter, and shall allow the Company and its representatives to participate
in any proceedings and discussions concerning such matters. Upon request, a Grantee shall provide to the Company any information or document
relating to any matter described in the preceding sentence, which the Company, in its discretion, requires.

 

    16

     

    

 

18.5.
With respect to 102 Non-Trustee Awards, if a Grantee ceases to be engaged by the Company or any Affiliate, the Grantee shall extend to
the Company and/or its Affiliate with whom the Grantee is employed a security or guarantee for the payment of taxes due at the time of
sale of Shares, all in accordance with the provisions of Section 102 of the Ordinance and the Rules.

 

19.
RIGHTS AS A SHAREHOLDER; VOTING AND DIVIDENDS.

 

19.1.
Subject to Section ‎ 11.7, a Grantee shall have no rights as a shareholder of the Company with respect to any Shares covered by an
Award until the Grantee shall have exercised the Award (in the case of an Option or similar Award), paid the exercise price (to the extent
applicable) and become the record holder of the subject Shares. In the case of 102 Option Awards or 3(9) Option Awards (if such Options
are being held by a Trustee), the Trustee shall have no rights as a shareholder of the Company with respect to the Shares covered by
such Award until the Trustee becomes the record holder of such Shares for the Grantee’s benefit, and the Grantee shall have no
rights as a shareholder of the Company with respect to the Shares covered by the Award until the date of the release of such Shares from
the Trustee to the Company’s Nominee Company for the benefit of Grantee and the transfer of record (beneficial) ownership of such
Shares to the Grantee. No adjustment shall be made for dividends (ordinary or extraordinary, whether in cash, securities or other property)
or distribution of other rights for which the record date is prior to the date on which the Grantee or Trustee (as applicable) becomes
the beneficial record holder of the Shares covered by an Award, except as provided in Section ‎ 14 hereof.

 

19.2.
With respect to all Awards issued in the form of Shares hereunder or upon the exercise of Awards hereunder, any and all voting rights
attached to such Shares shall be subject to Section ‎ 6.9, and the Grantee shall be entitled to receive dividends distributed with
respect to such Shares, subject to the provisions of the Company’s Articles of Association, as amended from time to time, and subject
to any Applicable Law.

 

19.3.
The Company may, but shall not be obligated to, register or qualify the sale of Shares under any applicable securities law or any other
applicable law.

 

19.4
It is clarified that all Shares and other tradable securities of the Company are held by either the Company’s Nominee Company acting
as custodian for such securities (at the Effective Date - the Registration Company of Bank Mizrachi), or the depositary for the Company’s
ADS program (at the Effective Date - The Bank of New York Mellon) and accordingly all Shares and other tradable securities which may
be issued to Grantee as a result of the exercise of Options shall be issued under the name of the Nominee Company with instructions that
Grantee shall be listed as beneficial shareholder of record.

 

20.
NO REPRESENTATION BY COMPANY.

 

By
granting Awards, the Company is not, and shall not be deemed as, making any representation or warranties to a Grantee regarding the Company,
its business affairs, its prospects or the future value of its Shares.

 

21.
NO RETENTION RIGHTS.

 

Nothing
in the Plan or in any Award granted or agreement entered into pursuant hereto shall confer upon any Grantee the right to continue in
the employ of, or be in a consultant, advisor, director, officer or supplier relationship with, the Company or any Subsidiary or Affiliate
or to be entitled to any remuneration or benefits not set forth in the Plan or such agreement or to interfere with or limit in any way
the right of the Company or any such Subsidiary or Affiliate to terminate such Grantee’s employment or service. Awards granted
under the Plan shall not be affected by any change in duties or position of a Grantee as long as such Grantee continues to be employed
by, or be in a consultant, advisor, director, officer or supplier relationship with, the Company or any Subsidiary or Affiliate.

 

22.
PERIOD DURING WHICH AWARDS MAY BE GRANTED.

 

Awards
may be granted pursuant to the Plan from time to time within a period of ten (10) years from the Effective Date. From and after the tenth
(10th) anniversary of the Effective Date no grants of Awards may be made and the Plan shall continue to be in full force and
effect solely with respect to such Awards that remain outstanding. The Plan shall terminate at such time after the tenth (10th)
anniversary of the Effective Date as no Awards remain outstanding.

 

    17

     

    

 

23.
TERM OF AWARD

 

Anything
herein to the contrary notwithstanding, but without derogating from the provisions of Sections ‎ 6.6, ‎ 6.7 or ‎ 8.3 hereof,
if any Award, or any part thereof, has not been exercised and the Shares covered thereby not paid for within the term of the Award as
determined by the Committee, which in any event shall not exceed ten (10) years after the date on which the Award was granted, as set
forth in the Notice of Grant in the Grantee’s Award, such Award, or such part thereof, and the right to acquire such Shares, shall
terminate, and all interests and rights of the Grantee in and to the same shall expire. In the case of Shares held by a Trustee, the
Grantee shall elect whether to release such Shares from trust or sell the Shares and upon such release or sale such trust shall expire.

 

24.
AMENDMENT AND TERMINATION OF THE PLAN.

 

The
Board at any time and from time to time may suspend, terminate, modify or amend the Plan, whether retroactively or prospectively; provided,
however, that, unless otherwise determined by the Board, an amendment which requires shareholder approval in order for the Plan to continue
to comply with any Applicable Law shall not be effective unless approved by the requisite vote of shareholders, and provided further,
that except as provided herein, no suspension, termination, modification or amendment of the Plan may adversely affect any Award previously
granted, without the written consent of Grantees holding a majority in interest of the Awards so affected, and in the event that such
consent is obtained, all Awards so affected shall be deemed amended, and the holders thereof shall be bound, as set forth in such consent.

 

25.
APPROVAL.

 

25.1.
The Plan shall take effect upon its adoption by the Board (the “Effective Date”), except that solely with respect to grants
of Incentive Stock Options the Plan shall also be subject to approval within one year of the Effective Date, by a majority of the votes
cast on the proposal at a meeting or a written consent of shareholders. Failure to obtain approval by the shareholders shall not in any
way derogate from the valid and binding effect of any grant of an Award that is not an Incentive Stock Option. Upon approval of the Plan
by the shareholders of the Company as set forth above, all Incentive Stock Options granted under the Plan on or after the Effective Date
shall be fully effective as if the shareholders of the Company had approved the Plan on the Effective Date. Notwithstanding the foregoing,
in the event that approval of the Plan by the shareholders of the Company is required under Applicable Law, in connection with the application
of certain tax treatment or pursuant to applicable stock exchange rules or regulations or otherwise, such approval shall be obtained
within the time required under the Applicable Law.

 

25.2.
The 102 Awards are subject to the approval, if required, of the ITA and receipt by the Company of all approvals thereof.

 

26.
RULES PARTICULAR TO SPECIFIC COUNTRIES; SECTION 409A

 

Notwithstanding
anything herein to the contrary, the terms and conditions of the Plan may be amended with respect to a particular country by means of
an appendix to the Plan, and to the extent that the terms and conditions set forth in any appendix conflict with any provisions of the
Plan, the provisions of the appendix shall govern. Terms and conditions set forth in the Appendix shall apply only to Awards granted
to Grantees under the jurisdiction of the specific country that is the subject of the appendix and shall not apply to Awards issued to
Grantees not under the jurisdiction of such country. The adoption of any such appendix shall be subject to the approval of the Board
or Committee, and if required in connection with the application of certain tax treatment, pursuant to applicable stock exchange rules
or regulations, or otherwise, also the approval of the requisite majority of the shareholders of the Company. To the extent applicable,
the Plan and any agreement hereunder shall be interpreted in accordance with Section 409A of the Code. Notwithstanding any provision
of the Plan to the contrary, in the event that, following the Effective Date, the Board determines that any Award may be subject to Section
409A of the Code, the Board may adopt such amendments to the Plan and to the relevant agreement governing the Award or adopt other policies
and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, that the Board determines
are necessary or appropriate to (a) exempt the Award from Section 409A of the Code and/or preserve the intended tax treatment of the
benefits provided with respect to the Award or (b) comply with the requirements of Section 409A of the Code.

 

    18

     

    

 

27.
GOVERNING LAW; JURISDICTION.

 

The
Plan and all determinations made and actions taken pursuant hereto shall be governed by the laws of the State of Israel, except with
respect to matters that are subject to tax laws, regulations and rules in any specific jurisdiction, which shall be governed by the respective
laws, regulations and rules of such jurisdiction. Certain definitions, which refer to laws other than the laws of such jurisdiction,
shall be construed in accordance with such other laws. The courts of competent jurisdiction located in Tel-Aviv-Jaffa, Israel shall have
exclusive jurisdiction over any dispute arising out of or in connection with this Plan and any Award granted hereunder, and by signing
any agreement relating to an Award hereunder each Grantee irrevocably submits to such exclusive jurisdiction.

 

28.
NON-EXCLUSIVITY OF THE PLAN.

 

Neither
the adoption of the Plan by the Board nor the submission of the Plan to shareholders of the Company for approval (to the extent required
under Applicable Law), shall be construed as creating any limitations on the power or authority of the Board to adopt such other or additional
incentive or other compensation arrangements of whatever nature as the Board may deem necessary or desirable or preclude or limit the
continuation of any other plan, practice or arrangement for the payment of compensation or fringe benefits to employees generally, or
to any class or group of employees, which the Company or any Subsidiary now has lawfully put into effect, including, without limitation,
any retirement, pension, savings and stock purchase plan, insurance, death and disability benefits and executive short-term or long-term
incentive plans.

 

29.
MISCELLANEOUS.

 

29.1.
Additional Terms. Each Award awarded under the Plan may contain such other terms and conditions not inconsistent with the Plan as may
be determined by the Committee, in its sole discretion.

 

29.2.
Severability. If any provision of the Plan or any Option Agreement, Restricted Share Agreement, Restricted Share Unit Agreement or any
other agreement entered into in connection with an Award shall be determined to be illegal or unenforceable by any court of law in any
jurisdiction, the remaining provisions hereof and thereof shall be severable and enforceable in accordance with their terms, and all
provisions shall remain enforceable in any other jurisdiction. In addition, if any particular provision contained in the Plan or any
Option Agreement, Restricted Share Agreement, Restricted Share Unit Agreement or any other agreement entered into in connection with
an Award shall for any reason be held to be excessively broad as to duration, geographic scope, activity or subject, it shall be construed
by limiting and reducing such provision as to such characteristic so that the provision is enforceable to fullest extent compatible with
the Applicable Law as it shall then appear.

 

29.3.
Captions and Titles. The use of captions and titles in this Plan or any Option Agreement, Restricted Share Agreement Restricted Share
Unit Agreement or any other agreement entered into in connection with an Award is for the convenience of reference only and shall not
affect the meaning of any provision of the Plan or such agreement.

 

*
* *

 

19

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00341-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00341-of-00352.parquet"}]]